
<html lang="en"     class="pb-page"  data-request-id="bd9a6075-3a2e-4daf-8a6d-cb6974d7f85c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm701208v;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2008.51.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Antitumor Agents 260. New Desmosdumotin B Analogues with Improved In Vitro Anticancer Activity" /></meta><meta name="dc.Creator" content="Kyoko  Nakagawa-Goto" /></meta><meta name="dc.Creator" content="Kenneth F.  Bastow" /></meta><meta name="dc.Creator" content="Tzu-Hsuan  Chen" /></meta><meta name="dc.Creator" content="Susan L.  Morris-Natschke" /></meta><meta name="dc.Creator" content="Kuo-Hsiung  Lee" /></meta><meta name="dc.Description" content="Sixteen analogues (3−16, 33, and 48) of the unique flavonoid desmosdumotin B (1) were prepared and evaluated as in vitro inhibitors of the human KB cancer cell line and its MDR subclone, KB-VIN. 6,..." /></meta><meta name="Description" content="Sixteen analogues (3−16, 33, and 48) of the unique flavonoid desmosdumotin B (1) were prepared and evaluated as in vitro inhibitors of the human KB cancer cell line and its MDR subclone, KB-VIN. 6,..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 13, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701208v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701208v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701208v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701208v" /></link>
        
    
    

<title>Antitumor Agents 260. New Desmosdumotin B Analogues with Improved In Vitro Anticancer Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701208v" /></meta><meta property="og:title" content="Antitumor Agents 260. New Desmosdumotin B Analogues with Improved In Vitro Anticancer Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0005.jpeg" /></meta><meta property="og:description" content=" Sixteen analogues (3−16, 33, and 48) of the unique flavonoid desmosdumotin B (1) were prepared and evaluated as in vitro inhibitors of the human KB cancer cell line and its MDR subclone, KB-VIN. 6,8,8-Triethyl analogues 10−13 showed enhanced KB-VIN selectivity. In particular, 4′-alkyl derivatives 11 (4′-Me) and 12 (4′-Et) showed significant ED50 values of 0.03 and 0.025 µg/mL, respectively, against KB-VIN with selectivities of &gt;460- and 320-fold compared with that of KB. This report is the first to describe compounds showing such high activity against MDR cells versus non-MDR cells. The unique activity of 1-analogues is likely MDR-mediated because cotreatment with verapamil, a P-gp inhibitor, partially reversed the selective toxicity of both 1 and 10. Interestingly, only 1-analogues with a naphthalene B-ring (8 and 14) showed significant cytotoxic activity against KB and other cancer cell lines. Thus, 1-analogues might be a new class of potent drug candidates, especially as 11 and 12 express direct selective action against tumors expressing MDR." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701208v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701208v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701208v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701208v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701208v&amp;href=/doi/10.1021/jm701208v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 3297-3303</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800002y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800026x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Antitumor Agents 260. New Desmosdumotin B Analogues with Improved In Vitro Anticancer Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyoko++Nakagawa-Goto">Kyoko Nakagawa-Goto</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+F.++Bastow">Kenneth F. Bastow</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tzu-Hsuan++Chen">Tzu-Hsuan Chen</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+L.++Morris-Natschke">Susan L. Morris-Natschke</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuo-Hsiung++Lee">Kuo-Hsiung Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599</span></div><div class="corresp-info"><strong>*</strong> Corresponding authors. E-mail: <a href="/cdn-cgi/l/email-protection#accbc3d8c3ecc9c1cdc5c082d9c2cf82c9c8d9"><span class="__cf_email__" data-cfemail="b4d3dbc0dbf4d1d9d5ddd89ac1dad79ad1d0c1">[email protected]</span></a> (K.N.G.); <a href="/cdn-cgi/l/email-protection#3e555b50615c5f4d4a51497e4b505d105b5a4b"><span class="__cf_email__" data-cfemail="2c474942734e4d5f58435b6c59424f02494859">[email protected]</span></a> (K.F.B.); <a href="/cdn-cgi/l/email-protection#583330343d3d182d363b763d3c2d"><span class="__cf_email__" data-cfemail="7e1516121b1b3e0b101d501b1a0b">[email protected]</span></a> (K.H.L.). Phone: 919-843-6325 (K.N.G.); 919-966-7633 (K.F.B.); 919-962-0066 (K.H.L.). Fax: 919-966-3893 (K.N.G.); 919-966-0204 (K.F.B.); 919-966-3893 (K.H.L.).</div><div class="corresp-fn" id="afn1">†Natural Products Research Laboratories, School of Pharmacy, University of North Carolina.</div><div class="corresp-fn" id="afn2">‡Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701208v&amp;href=/doi/10.1021%2Fjm701208v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 3297–3303</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 13, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 September 2007</li><li><span class="item_label"><b>Published</b> online</span>13 May 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 June 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701208v" title="DOI URL">https://doi.org/10.1021/jm701208v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3297%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKyoko%2BNakagawa-Goto%252C%2BKenneth%2BF.%2BBastow%252C%2BTzu-Hsuan%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D11%26contentID%3Djm701208v%26title%3DAntitumor%2BAgents%2B260.%2BNew%2BDesmosdumotin%2BB%2BAnalogues%2Bwith%2BImproved%2BIn%2BVitro%2BAnticancer%2BActivity%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3303%26publicationDate%3DJune%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701208v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">918</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701208v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Antitumor Agents 260. New Desmosdumotin B Analogues with Improved In Vitro Anticancer Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kyoko&quot;,&quot;last_name&quot;:&quot;Nakagawa-Goto&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;F. Bastow&quot;},{&quot;first_name&quot;:&quot;Tzu-Hsuan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;L. Morris-Natschke&quot;},{&quot;first_name&quot;:&quot;Kuo-Hsiung&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;3297-3303&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701208v&quot;},&quot;abstract&quot;:&quot;Sixteen analogues (3−16, 33, and 48) of the unique flavonoid desmosdumotin B (1) were prepared and evaluated as in vitro inhibitors of the human KB cancer cell line and its MDR subclone, KB-VIN. 6,8,8-Triethyl analogues 10−13 showed enhanced KB-VIN selectivity. In particular, 4′-alkyl derivatives 11 (4′-Me) and 12 (4′-Et) showed significant ED50 values of 0.03 and 0.025 µg/mL, respectively, against KB-VIN with selectivities of &gt;460- and 320-fold compared with that of KB. This report is the first to describe compounds showing such high activity against MDR cells versus non-MDR cells. The unique activity of 1-analogues is likely MDR-mediated because cotreatment with verapamil, a P-gp inhibitor, partially reversed the selective toxicity of both 1 and 10. Interestingly, only 1-analogues with a naphthalene B-ring (8 and 14) showed significant cytotoxic activity against KB and other cancer cell lines. Thus, 1-analogues might be a new class of potent drug candidates, especially as 11 and 12 express direct selective &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701208v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701208v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701208v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701208v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701208v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701208v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701208v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701208v&amp;href=/doi/10.1021/jm701208v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701208v" /></input><a href="/doi/pdf/10.1021/jm701208v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (129 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701208v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701208v%26sid%3Dliteratum%253Aachs%26pmid%3D18473435%26genre%3Darticle%26aulast%3DNakagawa-Goto%26date%3D2008%26atitle%3DAntitumor%2BAgents%2B260.%2BNew%2BDesmosdumotin%2BB%2BAnalogues%2Bwith%2BImproved%2BIn%2BVitro%2BAnticancer%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D11%26spage%3D3297%26epage%3D3303%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Sixteen analogues (<b>3−16</b>, <b>33</b>, and <b>48</b>) of the unique flavonoid desmosdumotin B (<b>1</b>) were prepared and evaluated as in vitro inhibitors of the human KB cancer cell line and its MDR subclone, KB-VIN. 6,8,8-Triethyl analogues <b>10</b>−<b>13</b> showed enhanced KB-VIN selectivity. In particular, 4′-alkyl derivatives <b>11</b> (4′-Me) and <b>12</b> (4′-Et) showed significant ED<sub>50</sub> values of 0.03 and 0.025 µg/mL, respectively, against KB-VIN with selectivities of >460- and 320-fold compared with that of KB. This report is the first to describe compounds showing such high activity against MDR cells versus non-MDR cells. The unique activity of <b>1</b>-analogues is likely MDR-mediated because cotreatment with verapamil, a P-gp inhibitor, partially reversed the selective toxicity of both <b>1</b> and <b>10</b>. Interestingly, only <b>1</b>-analogues with a naphthalene B-ring (<b>8</b> and <b>14</b>) showed significant cytotoxic activity against KB and other cancer cell lines. Thus, <b>1</b>-analogues might be a new class of potent drug candidates, especially as <b>11</b> and <b>12</b> express direct selective action against tumors expressing MDR.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chemotherapy is a useful treatment for cancer. However, its usefulness is often obstructed by the intrinsic or acquired resistance of cancer cells to anticancer drugs.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Resistance to one drug often implies simultaneous resistance to structurally and mechanistically diverse anticancer drugs, called multidrug resistance (MDR).<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3-7)</a> This efflux phenotype is mediated in part by the overexpression of plasma membrane transporters, including P-glycoprotein (P-gp, MDR1 or ABCB1)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> or the multidrug resistance-associated protein (MRP1 or ABCC1),<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> which both belong to the superfamily of ATP-binding-cassette (ABC) transporters.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The emergence of MDR pumps anticancer drugs out of the cell utilizing the energy of ATP hydrolysis and thus results in reducing intracellular drug concentrations below cytotoxic levels. As a result, tumor cells overexpressing MDR show resistance to most of the currently used antitumor drugs. The development of agents targeted toward MDR1 or MRP1 is greatly needed in order to improve anticancer chemotherapeutic strategies.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13-17)</a> MDR1/P-gp is the best characterized factor of the efflux system and most important mediator of MDR. Therefore, the major pharmacological approaches to overcome MDR have been focused on exploring the reversal of P-gp mediated MDR by inhibiting the function and suppressing the expression of MDR.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> Numerous compounds have been found and examined as MDR modulators that inhibit P-gp function and are classified into first, second, and third generation chemosensitizers. Many second and third generation chemosensitizers, some of which are currently in clinical trials, are more potent and less toxic than first generation compounds like verapamil or cyclosporin A, yet they still suffer from adverse effects, poor solubility, and undesirable changes in pharmacokinetics present with many marketed antitumor drugs.</div><div class="NLM_p">Among many MDR modulator candidates, flavonoids are compounds capable of modulating P-gp, hMRP1 transport, and ATPase activities.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> We recently found that the flavone desmosdumotin B (DesB, <b>1</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and its possible biosynthetic intermediate chalcone, desmosdumotin C (DesC, <b>2</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> showed higher activity against the P-gp-expressing multidrug-resistant KB-VIN cell line (vincristine-resistant KB) than its parental nonresistant KB tumor cell (human epidermoid carcinoma of the nasopharynx). Interestingly, DesB (<b>1</b>) strongly inhibited the growth of KB-VIN cells with an ED<sub>50</sub> value of 2.0 µg/mL,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> while it showed no activity against the other tested tumor cell lines, including the parental KB cell line (ED<sub>50</sub> >40 µg/mL). The amazing selective activity against only MDR cells, with a >20-fold selectivity for KB-VIN versus KB, implies that desmosdumotins act via unusual mechanisms that differ from those of classical MDR modulators, which are inhibitors of the efflux pump. <figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_p">We have previously accomplished the total synthesis of both <b>1</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and <b>2</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and the published routes have wide-ranging application for future analogue syntheses. Focused modification of <b>2</b> and the bioactivity of the resulting analogues have also been reported.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> We have continued the syntheses of <b>1</b>-analogues and evaluation of in vitro anticancer activity, mainly focused against non-MDR (KB) and MDR (KB-VIN) cell lines. Herein, we report the syntheses and bioactivity of novel <b>1</b>-analogues as well as observed structure−activity relationships (SAR) in detail.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Chemistry</h3><div class="NLM_p">Fourteen <b>1</b>-analogues, <b>3</b>−<b>16</b>, were synthesized from the related <b>2</b>-analogues through intramolecular cyclization and demethylation transformations as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Three <b>2</b>-analogues, <b>29</b>−<b>31</b>, were newly synthesized from 2,4,6-trihydroxyacetophenone (<b>34</b>) according to the methodology in our prior report,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and 13 <b>2</b>-analogues, <b>17</b>−<b>28</b>, and <b>32</b>, were prepared previously.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compounds <b>17</b>, <b>18</b>, <b>20−23</b>, and <b>26</b> were converted directly to the related <b>1</b>-analogues, <b>3</b>−<b>8</b> and <b>10</b>, by heating at 80−95 °C with catalytic iodine and 1−2% conc H<sub>2</sub>SO<sub>4</sub> in DMSO for several hours in moderate yields. However, certain compounds (e.g., <b>19</b>, <b>21</b>, and <b>26</b>) gave unsatisfying low yield of products, even employing a higher temperature and longer reaction time. Bulkiness in the aryl ring (2′,6′-dimethylphenyl for <b>19</b> and <b>21</b>) or at the C-8 position (<i>gem</i>-diethyl groups for <b>26</b>) might hinder the reaction. Alternatively, a two-step conversion involving cyclization followed by demethylation was carried out to improve the yield (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). At this point, a shorter reaction time (less than 1.5 h) was used for the cyclization step to avoid demethylation and decomposition. For example, compound <b>26</b> was heated at 95 °C for 1.5 h in the presence of catalytic iodine and 1−2% conc H<sub>2</sub>SO<sub>4</sub> in DMSO to obtain methylated <b>40</b> in 68% yield along with <b>10</b> in 19% yield. Demethylation of <b>40</b> was performed by using 3 mol equiv of BBr<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub> to afford <b>10</b> in 82% yield (79% overall yield for two steps). This improved method was applied to the remaining <b>2</b>-analogues, <b>25</b>−<b>32</b>, to give the desired compounds <b>9</b>−<b>16</b> in 62−82% overall yields in two steps through <b>39</b>−<b>46</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0003.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of <b>1</b>-Analogues</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (i) RI (3 mol equiv), NaOMe (3 mol equiv), MeOH, reflux. (R = Me for <b>35a</b>, R = Et for <b>35d</b>, R = Pr for <b>35e</b>). (ii) (1) BF<sub>3</sub>·OEt<sub>2</sub>, HOAc/Ac<sub>2</sub>O, (2) MeI, NaOMe, MeOH, reflux, (3) 85% H<sub>2</sub>SO<sub>4</sub>, heat, (4) EtI (2 mol equiv), NaOMe (1 mol equiv), MeOH, reflux. (iii) TMSCHN<sub>2</sub>, −78 to −40°C. (iv) ArCHO, 50% KOH, EtOH, rt, 1−3 days. (v) I<sub>2</sub>, DMSO, conc H<sub>2</sub>SO<sub>4</sub>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. (vi) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt. (vii) (1) PhCHO, 50% KOH, EtOH, microwave, 90 °C, 20 min; (2) I<sub>2</sub>, DMSO, microwave, 190 °C, 5 min.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0004.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of isoflavone <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) EtI (3 mol equiv), NaOMe (3 mol equiv), MeOH, reflux, 50%. (ii) BF<sub>3</sub>·OEt<sub>2</sub>, PCl<sub>5</sub>, DMF, 68%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Conditions of Cyclization Step (Method A: Direct Conversion)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">starting material (mmol)</th><th align="center" valign="bottom" char=".">1−2% conc H<sub>2</sub>SO<sub>4</sub> in DMSO (mL)</th><th align="center" valign="bottom">temp (°C)</th><th align="center" valign="bottom" char=".">time (h)</th><th align="center" valign="bottom" char=".">product (% yield)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>17</b> (0.15)</td><td align="char" valign="top" char=".">1.5</td><td align="left" valign="top">90</td><td align="char" valign="top" char=".">5</td><td align="char" valign="top" char="."><b>3</b> (52)</td></tr><tr valign="top"><td align="left" valign="top"><b>18</b> (0.16)</td><td align="char" valign="top" char=".">1.8</td><td align="left" valign="top">90</td><td align="char" valign="top" char=".">6</td><td align="char" valign="top" char="."><b>4</b> (48)</td></tr><tr valign="top"><td align="left" valign="top"><b>20</b> (0.17)</td><td align="char" valign="top" char=".">2.0</td><td align="left" valign="top">80</td><td align="char" valign="top" char=".">5</td><td align="char" valign="top" char="."><b>5</b> (44)</td></tr><tr valign="top"><td align="left" valign="top"><b>21</b> (0.34)</td><td align="char" valign="top" char=".">2.3</td><td align="left" valign="top">80−100</td><td align="char" valign="top" char=".">24</td><td align="char" valign="top" char="."><b>6</b> (10)</td></tr><tr valign="top"><td align="left" valign="top"><b>22</b> (0.12)</td><td align="char" valign="top" char=".">1.2</td><td align="left" valign="top">95</td><td align="char" valign="top" char=".">6</td><td align="char" valign="top" char="."><b>7</b> (51)</td></tr><tr valign="top"><td align="left" valign="top"><b>23</b> (0.13)</td><td align="char" valign="top" char=".">1.8</td><td align="left" valign="top">90</td><td align="char" valign="top" char=".">6</td><td align="char" valign="top" char="."><b>8</b> (45)</td></tr><tr valign="top"><td align="left" valign="top"><b>26</b> (0.24)</td><td align="char" valign="top" char=".">2.3</td><td align="left" valign="top">90−100</td><td align="char" valign="top" char=".">7</td><td align="char" valign="top" char="."><b>10</b> (10)</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Conditions of Cyclization Step (Method B: Two-Step Conversion)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">starting material (mmol)</th><th align="center" valign="bottom" char=".">1−2% conc H<sub>2</sub>SO<sub>4</sub> in DMSO (mL)</th><th align="center" valign="bottom" char=".">temp (°C)</th><th align="center" valign="bottom" char=".">time (min)</th><th colspan="2" align="center" valign="middle">products in step 1 (% yield)</th><th align="center" valign="bottom">product in step 2<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a> (% yield)</th><th align="center" valign="bottom" char=".">overall % yield in two steps</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>25</b> (0.28)</td><td align="char" valign="top" char=".">1.8</td><td align="char" valign="top" char=".">95</td><td align="char" valign="top" char=".">60</td><td align="left" valign="top"><b>9</b> (41)</td><td align="left" valign="top"><b>39</b> (34)</td><td align="left" valign="top"><b>9</b> (74)</td><td align="char" valign="top" char=".">66</td></tr><tr valign="top"><td align="left" valign="top"><b>26</b> (0.22)</td><td align="char" valign="top" char=".">1.6</td><td align="char" valign="top" char=".">95</td><td align="char" valign="top" char=".">90</td><td align="left" valign="top"><b>10</b> (19)</td><td align="left" valign="top"><b>40</b> (68)</td><td align="left" valign="top"><b>10</b> (82)</td><td align="char" valign="top" char=".">79</td></tr><tr valign="top"><td align="left" valign="top"><b>27</b> (0.19)</td><td align="char" valign="top" char=".">1.7</td><td align="char" valign="top" char=".">95</td><td align="char" valign="top" char=".">50</td><td align="left" valign="top"><b>11</b> (8)</td><td align="left" valign="top"><b>41</b> (72)</td><td align="left" valign="top"><b>11</b> (76)</td><td align="char" valign="top" char=".">62</td></tr><tr valign="top"><td align="left" valign="top"><b>28</b> (0.12)</td><td align="char" valign="top" char=".">1.2</td><td align="char" valign="top" char=".">95</td><td align="char" valign="top" char=".">60</td><td colspan="2" align="center" valign="top">w/o separation</td><td align="left" valign="top"><b>12</b> (−)</td><td align="char" valign="top" char=".">64</td></tr><tr valign="top"><td align="left" valign="top"><b>29</b> (0.31)</td><td align="char" valign="top" char=".">1.7</td><td align="char" valign="top" char=".">90</td><td align="char" valign="top" char=".">90</td><td colspan="2" align="center" valign="top">w/o separation</td><td align="left" valign="top"><b>13</b> (−)</td><td align="char" valign="top" char=".">66</td></tr><tr valign="top"><td align="left" valign="top"><b>30</b> (0.11)</td><td align="char" valign="top" char=".">1.8</td><td align="char" valign="top" char=".">90</td><td align="char" valign="top" char=".">60</td><td colspan="2" align="center" valign="top">w/o separation</td><td align="left" valign="top"><b>14</b> (−)</td><td align="char" valign="top" char=".">82</td></tr><tr valign="top"><td align="left" valign="top"><b>31</b> (0.08)</td><td align="char" valign="top" char=".">1.7</td><td align="char" valign="top" char=".">90</td><td align="char" valign="top" char=".">60</td><td colspan="2" align="center" valign="top">w/o separation</td><td align="left" valign="top"><b>15</b> (−)</td><td align="char" valign="top" char=".">71</td></tr><tr valign="top"><td align="left" valign="top"><b>32</b> (0.34)</td><td align="char" valign="top" char=".">1.6</td><td align="char" valign="top" char=".">95</td><td align="char" valign="top" char=".">90</td><td align="left" valign="top"><b>16</b> (2)</td><td align="left" valign="top"><b>46</b> (75)</td><td align="left" valign="top"><b>16</b> (90)</td><td align="char" valign="top" char=".">76</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">BBr<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub> rt overnight from <b>39</b>−<b>46</b>.</p></div></div></div><div class="NLM_p">However, as our synthetic focus was on <b>1</b>-analogues, we also designed a synthetic pathway that avoided the corresponding <b>2</b>-analogues as intermediates. Aldol condensation of <b>35d</b> with phenylaldehyde in the presence of 50% aq KOH proceeded only under microwave conditions (90 °C, 20 min). The resulting aldol adduct was treated without purification with iodine in DMSO, again using microwave technology, to provide <b>10</b> in 35% overall yield. The overall yields using the two synthetic pathways (with or without the <b>2</b>-analogue intermediate) were almost identical. However, the direct pathway from <b>35d</b> to <b>10</b> had fewer reaction steps and required less time. Thus, we have developed an alternative synthetic pathway to <b>1</b>-analogues using microwave technology.</div><div class="NLM_p last">Three additional compounds (isoflavone <b>33</b>, flavone <b>48</b>, and flavanone <b>51</b>) were screened for cytotoxic activity in our SAR study. During ethylation of <b>34</b> to give <b>35d</b>, 3,5-diethylacetophenone (<b>47</b>) was produced as a side product. Compound <b>47</b> was converted to the related flavone <b>48</b> by the same reaction sequence indicated above. In addition, triethylation of 2,4,6-trihydroxy phenylacetophenone (<b>49</b>) was successfully achieved using the methods described above to afford <b>50</b> in moderate yield. Treatment of <b>50</b> with <i>N</i>,<i>N</i>-dimethyl(chloromethylene)ammonium chloride, generated by DMF and PCl<sub>5</sub>, in the presence of BF<sub>3</sub>·OEt<sub>2</sub>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> produced the desired isoflavone <b>33</b> in good yield. The last compound (<b>51</b>) investigated in our study was reported in our prior papers.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All synthesized <b>1</b>-analogues were evaluated in vitro against two human tumor cell lines, the KB-VIN cell line, which is an MDR P-gp-expressing cloned subline stepwise selected using vincristine, and its parental non-MDR KB cell line. Selected <b>1</b>-analogues were also evaluated in vitro against four additional human tumor cell lines, A549 (human lung carcinoma), MCF-7 (breast cancer), HCT-8 (colon adenocarcinoma), and PC-3 (prostate cancer).</div><div class="NLM_p">The cytotoxic activity data for <b>1</b> and its analogues <b>3−16</b>, <b>33</b>, <b>48</b>, and <b>51</b> are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Because the KB-VIN selectivity of <b>1</b> was higher than that of <b>2</b>, we hypothesized that analogues with the flavone skeleton would show enhanced inhibition of KB-VIN (MDR) cell growth with less activity against KB (non-MDR) cells than the related chalcone analogues. In fact, most <b>1</b>-analogues (<b>3</b>−<b>5</b>, <b>7</b>, and <b>9</b>−<b>13</b>) did show remarkably enhanced inhibition of the growth of KB-VIN cells but were not significantly cytotoxic against KB cells. These <b>1</b>-analogues had KB-VIN selectivities of 6.4−460 (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), while tested C-7 methylated analogues (<b>37</b>, <b>38</b>, <b>40</b>, and <b>46</b>) were not selective (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Important pharmacophores for the enhanced KB-VIN activity were a nonaromatic trialkyl A-ring, 2,3-double bond, and monophenyl B-ring, as discussed below.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Activities of 1-Analogues against KB and KB-VIN</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0006.gif" alt="" id="_i9" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th colspan="4" align="center" valign="middle">compound</th><th colspan="2" align="center" valign="middle">ED<sub>50</sub> (μg/mL)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th><th align="left" valign="middle"> </th></tr><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="bottom">R</th><th align="center" valign="bottom">R′</th><th align="center" valign="bottom">Ar</th><th align="center" valign="bottom">KB</th><th align="center" valign="bottom" char=".">KB-VIN</th><th align="center" valign="bottom">selectivity KB/KB-VIN</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>1</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">Me</td><td align="left" valign="top">Ph</td><td align="left" valign="top">>40 (33)</td><td align="char" valign="top" char=".">2.0</td><td align="left" valign="top">20</td></tr><tr valign="top"><td align="left" valign="top"><b>3</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">4-Me-Ph</td><td align="left" valign="top">22.54</td><td align="char" valign="top" char=".">1.09</td><td align="left" valign="top">20.7</td></tr><tr valign="top"><td align="left" valign="top"><b>4</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">2-Me-Ph</td><td align="left" valign="top">37.28</td><td align="char" valign="top" char=".">1.75</td><td align="left" valign="top">21.3</td></tr><tr valign="top"><td align="left" valign="top"><b>5</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">3,5-diMe-Ph</td><td align="left" valign="top">53.05</td><td align="char" valign="top" char=".">2.91</td><td align="left" valign="top">18.2</td></tr><tr valign="top"><td align="left" valign="top"><b>6</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">2,4,6-triMe-Ph</td><td align="left" valign="top">NA<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a></td><td align="char" valign="top" char=".">5.82</td><td align="left" valign="top">>3.4</td></tr><tr valign="top"><td align="left" valign="top"><b>7</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">4-Et-Ph</td><td align="left" valign="top">20.0</td><td align="char" valign="top" char=".">1.54</td><td align="left" valign="top">13.0</td></tr><tr valign="top"><td align="left" valign="top"><b>8</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">naphthalen-1-yl</td><td align="left" valign="top">0.51</td><td align="char" valign="top" char=".">0.16</td><td align="left" valign="top">3.2</td></tr><tr valign="top"><td align="left" valign="top"><b>9</b></td><td align="left" valign="top"> </td><td align="left" valign="top">Et</td><td align="left" valign="top">Ph</td><td align="left" valign="top">>20 (12)</td><td align="char" valign="top" char=".">0.6</td><td align="left" valign="top">>33</td></tr><tr valign="top"><td align="left" valign="top"><b>10</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">Et</td><td align="left" valign="top">Ph</td><td align="left" valign="top">>80</td><td align="char" valign="top" char=".">0.36</td><td align="left" valign="top">222</td></tr><tr valign="top"><td align="left" valign="top"><b>11</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">4-Me-Ph</td><td align="left" valign="top">13.8</td><td align="char" valign="top" char=".">0.03</td><td align="left" valign="top">460</td></tr><tr valign="top"><td align="left" valign="top"><b>12</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">4-Et-Ph</td><td align="left" valign="top">8.0</td><td align="char" valign="top" char=".">0.025</td><td align="left" valign="top">320</td></tr><tr valign="top"><td align="left" valign="top"><b>13</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">2-Me-Ph</td><td align="left" valign="top">18.0</td><td align="char" valign="top" char=".">0.1</td><td align="left" valign="top">60</td></tr><tr valign="top"><td align="left" valign="top"><b>14</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">naphthalen-1-yl</td><td align="left" valign="top">0.6</td><td align="char" valign="top" char=".">0.3</td><td align="left" valign="top">2.0</td></tr><tr valign="top"><td align="left" valign="top"><b>15</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">phenanthren-9-yl</td><td align="left" valign="top">5.0</td><td align="char" valign="top" char=".">4.3</td><td align="left" valign="top">1.2</td></tr><tr valign="top"><td align="left" valign="top"><b>16</b></td><td align="left" valign="top">Pr</td><td align="left" valign="top">Pr</td><td align="left" valign="top">Ph</td><td align="left" valign="top">4.0</td><td align="char" valign="top" char=".">0.63</td><td align="left" valign="top">6.4</td></tr><tr valign="top"><td align="left" valign="top"><b>33</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">16.0</td><td align="char" valign="top" char=".">3.5</td><td align="left" valign="top">4.6</td></tr><tr valign="top"><td align="left" valign="top"><b>48</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">>20 (18)</td><td align="char" valign="top" char=".">5.0</td><td align="left" valign="top">>4</td></tr><tr valign="top"><td align="left" valign="top"><b>51</b></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">10.5</td><td align="char" valign="top" char=".">7.5</td><td align="left" valign="top">1.4</td></tr><tr valign="top"><td align="left" valign="top"><b>VIN</b><a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a></td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top"> </td><td align="left" valign="top">0.015</td><td align="char" valign="top" char=".">7.0</td><td align="left" valign="top">0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Cytotoxicity as ED<sub>50</sub> values for each cell line, the concentration of compound that caused 50% reduction in absorbance at 562 nm relative to untreated cells using the sulforhodamine B assay.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Test compound (20 μg/mL) did not reach 50% inhibition.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">Vincristine.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activities of <b>37</b>, <b>38</b>, <b>40</b>, and <b>46</b> against KB and KB-VIN</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0007.gif" alt="" id="_i11" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th colspan="4" align="center" valign="middle">compound</th><th colspan="2" align="center" valign="middle" char=".">ED<sub>50</sub> (μg/mL)</th><th align="char" valign="middle" char="."> </th></tr><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle">R</th><th align="center" valign="middle">R′</th><th align="center" valign="middle">Ar</th><th align="center" valign="middle" char=".">KB</th><th align="center" valign="middle" char=".">KB-VIN</th><th align="center" valign="middle" char=".">selectivity KB/KB-VIN</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>37</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">Me</td><td align="left" valign="top">Ph</td><td align="char" valign="top" char=".">38.5</td><td align="char" valign="top" char=".">23.0</td><td align="char" valign="top" char=".">1.7</td></tr><tr valign="top"><td align="left" valign="top"><b>38</b></td><td align="left" valign="top">Me</td><td align="left" valign="top">H</td><td align="left" valign="top">Ph</td><td align="char" valign="top" char=".">1.8</td><td align="char" valign="top" char=".">1.8</td><td align="char" valign="top" char=".">1.0</td></tr><tr valign="top"><td align="left" valign="top"><b>40</b></td><td align="left" valign="top">Et</td><td align="left" valign="top">Et</td><td align="left" valign="top">Ph</td><td align="char" valign="top" char=".">20.0</td><td align="char" valign="top" char=".">15.5</td><td align="char" valign="top" char=".">1.3</td></tr><tr valign="top"><td align="left" valign="top"><b>46</b></td><td align="left" valign="top">Pr</td><td align="left" valign="top">Pr</td><td align="left" valign="top">Ph</td><td align="char" valign="top" char=".">8.5</td><td align="char" valign="top" char=".">7.0</td><td align="char" valign="top" char=".">1.2</td></tr></tbody></table></div></div><div class="NLM_p">Monoalkylated B-ring analogues <b>3</b>, <b>4</b>, and <b>7</b>, as well as 3,5-dimethyl analogue <b>5</b>, showed almost the same activity and selectivity as the nonsubstituted parent compound (<b>1</b>). However, the 2,4,6-trimethyl B-ring analogue <b>6</b> displayed decreased activity against KB-VIN cells. This finding could imply that the loss of rotational flexibility around the B−C ring axis caused by 2,6-disubstitution might adversely affect the cytotoxic activity against MDR cells.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In addition, analogues <b>8</b> and <b>14,</b> in which the phenyl B-ring was replaced with a naphthyl ring, strongly inhibited KB-VIN cell growth with ED<sub>50</sub> values of 0.16 and 0.3 µg/mL, although they also inhibited the parental KB cells with ED<sub>50</sub> values of 0.5 and 0.6 µg/mL, respectively. This result is interesting because <b>1</b>-analogues without a naphthyl ring did not show strong cytotoxic activity against KB cells.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Data for Selected of 1-Analogues against Various Cancer Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="left" valign="middle"> </th><th colspan="4" align="center" valign="middle">Ed<sub>50</sub> (µg/mL)</th></tr><tr valign="top"><th align="center" valign="middle">cmpd</th><th align="center" valign="middle">A549</th><th align="center" valign="middle">MCF-7</th><th align="center" valign="middle">HCT-8</th><th align="center" valign="middle">PC-3</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>1</b></td><td align="left" valign="top">>20(16)</td><td align="left" valign="top">>20(23)</td><td align="left" valign="top">NA</td><td align="left" valign="top">NA</td></tr><tr valign="top"><td align="left" valign="top"><b>8</b></td><td align="left" valign="top">0.6</td><td align="left" valign="top">0.6</td><td align="left" valign="top">0.4</td><td align="left" valign="top">0.5</td></tr><tr valign="top"><td align="left" valign="top"><b>10</b></td><td align="left" valign="top">NA</td><td align="left" valign="top">>20(38)</td><td align="left" valign="top">NA</td><td align="left" valign="top">NA</td></tr><tr valign="top"><td align="left" valign="top"><b>11</b></td><td align="left" valign="top">16.0</td><td align="left" valign="top">>20(38)</td><td align="left" valign="top">15.0</td><td align="left" valign="top">18.0</td></tr><tr valign="top"><td align="left" valign="top"><b>14</b></td><td align="left" valign="top">0.6</td><td align="left" valign="top">0.2</td><td align="left" valign="top">0.4</td><td align="left" valign="top">0.4</td></tr><tr valign="top"><td align="left" valign="top"><b>15</b></td><td align="left" valign="top">8.0</td><td align="left" valign="top">4.0</td><td align="left" valign="top">5.6</td><td align="left" valign="top">6.0</td></tr><tr valign="top"><td align="left" valign="top"><b>33</b></td><td align="left" valign="top">18.0</td><td align="left" valign="top">10.0</td><td align="left" valign="top">12.0</td><td align="left" valign="top">>20(32)</td></tr><tr valign="top"><td align="left" valign="top"><b>VIN</b></td><td align="left" valign="top">0.004</td><td align="left" valign="top">0.010</td><td align="left" valign="top">0.020</td><td align="left" valign="top">0.010</td></tr></tbody></table></div></div><div class="NLM_p">Among the A-ring analogues, changing the substituents on the A-ring caused dramatic effects on KB-VIN selectivity. Replacing the C-6 methyl group (<b>1</b>) with an ethyl group (<b>9</b>) resulted in increased cytotoxic activity against KB-VIN (ED<sub>50</sub> 0.6 versus 2.0 µg/mL) and, correspondingly, in enhanced KB-VIN selectivity (>33 versus 20). Furthermore, 6,8,8-triethyl-DesB <b>10</b>, in which all three A-ring methyl groups have been replaced with ethyl groups, possessed even greater activity against KB-VIN cells (ED<sub>50</sub> 0.36 µg/mL) without activity against the KB cell line, resulting in greater than 222-fold selectivity for the KB-VIN cell line. However, extending the substituent size to three carbons (6,8,8-tripropyl <b>16</b>) led to enhanced cytotoxic activity against both cell lines, MDR and non-MDR, with decreased KB-VIN selectivity of only 6.4. Although, as discussed above, B-ring alkylation of trimethyl substituted <b>1</b> had no or little effect on activity or selectivity, B-ring alkylation of triethyl-DesB (<b>10</b>) did have significant effects. Adding a 2′-Me (<b>13</b>) increased potency against both cell lines. More notably, introduction of either a methyl (<b>11</b>) or ethyl (<b>12</b>) at C-4′ greatly potentiated the inhibitory activity against KB-VIN cells, resulting in remarkably enhanced ED<sub>50</sub> values of 0.03 and 0.025 µg/mL, respectively. Because these two compounds did not significantly inhibit the parent KB cell growth, the KB-VIN selectivities for 4′-methyl <b>11</b> and 4′-ethyl <b>12</b> were 460 and 320, respectively.</div><div class="NLM_p">Comparison of <b>12</b> and <b>48</b> showed that an aromatized A-ring in the latter disturbed both activity and KB-VIN selectivity or, alternatively, that 6,8,8-trialkyl A-ring substitution was required for selectivity. Moreover, a C-2,3 double bond in the B-ring was also necessary because the flavanone <b>51</b> showed decreased activity against and no selectivity for KB-VIN compared to the related flavone <b>1</b>. Isoflavonoid analogue <b>33</b>, which has the B-ring connected to the C-3 position, also showed only 4.6-fold KB-VIN selectivity. In addition, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, putting a methoxy group at the C-7 position (enol ether) generally resulted in no inhibitory activity against KB-VIN or KB cells and no KB-VIN selectivity. The one exception was <b>38</b>, which showed potent activity against both KB and KB-VIN cell lines (ED<sub>50</sub> 1.8 µg/mL). This compound is unsubstituted at the C-6 position.</div><div class="NLM_p">As discussed above, most <b>1</b>-analogues tested possessed unique activity against KB-VIN cells with less or comparable activity against the parent tumor cell line. The following key SAR observations were found regarding the KB-VIN selectivity: (1) A flavone skeleton, as opposed to chalcone or flavanone, was important for the selectivity. (2) A 6,8,8-trialkyl nonaromatic A-ring resulted in better selectivity than a 6,8-dialkyl aromatic ring. (3) The rank order of selectivity for <b>1</b>-analogues decreased in the following order: 6,8,8-triethyl > 6-ethyl-8,8-dimethyl > 6,8,8-trimethyl > 6,8,8-tripropyl. (4) A 4′-alkyl group enhanced the selectivity in triethyl desB analogues and a methyl group was better than an ethyl group.</div><div class="NLM_p">Meanwhile, selected analogues (parent compound <b>1</b>, analogues <b>10</b> and <b>11</b>, which showed high selectivity for MDR (KB-VIN) versus non-MDR (KB) cells, naphthyl B-ring analogues <b>8</b> and <b>14,</b> which displayed potent cytotoxic activity against both KB and KB-VIN cell lines, and isoflavonoid <b>33</b>) were tested against additional cancer cell lines (Table 5). As was expected, analogues <b>8</b> and <b>14</b> showed significant cell growth inhibition against all tested cell lines, A549, MCF-7, HCT-8, and PC-3, with ED<sub>50</sub> values of 0.2−0.6 µg/mL. In contrast, no cytotoxic activity was observed with <b>1</b>, <b>10</b>, and <b>11</b> as well as <b>33.</b> The lack of cytotoxic activity against these cell lines suggested that P-gp might be necessary for the activity of these <b>1</b>-analogues.</div><div class="NLM_p">To examine whether functional P-gp was required for the unique activity of <b>1</b>-analogues against KB-VIN cells, experiments testing the effect of cotreatment with verapamil, a first generation P-gp inhibitor, were conducted. The results of this preliminary approach shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> clearly show that verapamil significantly reduced the selective toxicity of compounds <b>1</b> and <b>10</b>, suggesting that for these two agents, P-gp activity was indeed required. Advanced mechanistic investigations are now in progress, but it is worthwhile noting that the hyperactivity of <b>1</b> and <b>10</b>−<b>12</b> is not general for MDR-cell lines but is restricted to only a few (P. C. Chiang, K. H. Lee, and K. F. Bastow, unpublished observation). One possible explanation is that P-gp microheterogeneity is important in determining hypersensitivity. More than 50 single-nucleotide polymorphisms (SNP) are known, some of which are silent but which can still radically affect P-gp conformation (any can potentially alter drug interaction).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Efforts to test the importance of P-gp-microheterogeneity for the unprecedented high collateral sensitivity of KB-VIN and other MDR cell-lines to <b>11</b> are underway, and mechanistic work will be reported in due course.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reversal effects of <b>1</b> and <b>10</b> in KB-VIN cells by verapamil cotreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, 6,8,8-triethyl-4′-methyl analogue <b>11</b> possessed the most significant and unique activity in this study. It inhibited KB-VIN cell growth with an ED<sub>50</sub> value of 0.03 µg/mL, had no toxicity against the other tested cancer cells, including KB, and showed 460-fold KB-VIN selectivity. This surprising sensitivity of a MDR versus non-MDR cell line has not been reported since the U.S. National Cancer Institute (NCI) 60 cell line anticancer drug screen was developed in the late 1980s.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Currently, a thiosemicarbazone derivative, NSC73306,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> is undergoing advanced preclinical testing by NCI as a drug lead for targeting MDR tumor cell populations. It was selectively toxic to P-gp-expressing tumor cells; however, the sensitivity of KB-VIN (MDR)/KB-3-1 (non-MDR) was only 7.8-fold. The proposed mechanisms of action for NSC73306 do not involve direct interaction with P-gp but are P-gp-dependent and P-gp-specific. In our study, because <b>1</b>-analogues showed amazingly sensitive and potent cytotoxic activity against MDR cells with no inhibitory activity against non-MDR cells, these compounds seem to require the existence of P-gp for activity and might not act as normal MDR modulators, which inhibit the drug efflux pump and thereby reverse MDR via chemosensitization activity. Thus, although the mechanism of action of <b>1</b>-analogues is not yet clear, it might be unique and different from that of NSC73306. Triethyl-DesB analogues <b>10</b>−<b>12</b> could provide a new class of promising antitumor drug candidates able to overcome the current serious MDR problem. In addition, naphthyl analogues <b>8</b> and <b>14</b> showed significant cytotoxic activity against both MDR and non-MDR cell lines and would be good antitumor drug candidates that act regardless of the presence of P-gp.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemicals and solvents were used as purchased. All melting points were measured on a Fisher-Johns melting point apparatus without correction. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Varian Gemini 2000 (300 MHz) NMR spectrometer with TMS as the internal standard. All chemical shifts are reported in ppm. NMR spectra were referenced to the residual solvent peak, chemical shifts δ in ppm, apparent scalar coupling constants <i>J</i> in Hz. Mass spectroscopic data were obtained on a TRIO 1000 mass spectrometer. Analytical thin-layer chromatography (TLC) was carried out on Merck precoated aluminum silica gel sheets (Kieselgel 60 F-254). All target compounds were characterized by <sup>1</sup>H NMR, MS, and elemental analyses.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Synthetic Procedures for 1-Analogues</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Method A (Direct Conversion)</h4><div class="NLM_p last">Compounds <b>17</b>, <b>18</b>, <b>20</b>−<b>23</b>, and <b>26</b> were dissolved separately in 1−2% conc H<sub>2</sub>SO<sub>4</sub> in DMSO, and then I<sub>2</sub> (0.1 mol equiv) was added and the reaction mixture heated for several hours (see below). The reaction mixture was quenched with ice-cold aqueous 10% Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> and extracted with EtOAc. The extract was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was chromatographed on silica gel eluting with EtOAc−hexane (1:4 to 1:2, v/v) to afford analogues <b>3−8</b> and <b>10.</b></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Method B (Two-Step Conversion)</h4><div class="NLM_p last">Compounds <b>25−32</b> were dissolved separately in 1% conc H<sub>2</sub>SO<sub>4</sub> in DMSO, and then I<sub>2</sub> (0.1 mol equiv) was added and the reaction mixture heated at 90−95 °C for 1 h. The reaction mixture was treated in the same manner as described above to afford 7-methoxy substituted analogues <b>39</b>−<b>46</b>, along with a small amount of <b>9</b>−<b>16</b>. Compounds <b>39</b>−<b>46</b> were dissolved separately in anhydrous CH<sub>2</sub>Cl<sub>2</sub>, and the mixture cooled to 0 °C. BBr<sub>3</sub> (3 mol equiv, 1.0 M solution in CH<sub>2</sub>Cl<sub>2</sub>) was added to the solution, which was warmed to rt spontaneously and stirred overnight. After addition of water, the reaction mixture was extracted three times with CH<sub>2</sub>Cl<sub>2</sub>. The extracts were combined, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was chromatographed on silica gel eluting with EtOAc−hexane (1:4) to obtain analogues <b>9</b>−<b>16</b>.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 4′-Methyl desmosdumotin B (<b>3</b>)</h4><div class="NLM_p last">Yellow prisms, mp 201−202 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.16 (s, 1H, chelated-O<i>H</i>), 7.70 (d, 2H, <i>J</i> = 8.2 Hz, 2′- and 6′-<i>H</i>), 7.36 (d, 2H, <i>J</i> = 8.2 Hz, 3′- and 5′-<i>H</i>), 6.86 (s, 1H, 3-<i>H</i>), 2.46 (s, 3H, 4′-C<i>H</i><sub>3</sub>), 1.88 (s, 3H, 6-C<i>H</i><sub>3</sub>), 1.58 (s, 6H, 8-<i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 311 (M<sup>+</sup> + 1). Anal. (C<sub>19</sub>H<sub>18</sub>O<sub>4</sub>·<sup>1</sup>/<sub>4</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 2′-Methyl desmosdumotin B (<b>4</b>)</h4><div class="NLM_p last">Yellow prisms, mp 146−147 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.10 (s, 1H, chelated-O<i>H</i>), 7.51−7.44 (m, 2H, Ar-<i>H</i> × 2), 7.40−7.31 (m, 2H, Ar-<i>H</i> × 2), 6.61 (s, 1H, 3-<i>H</i>), 2.47 (s, 3H, 4′-C<i>H</i><sub>3</sub>), 1.88 (s, 3H, 6-C<i>H</i><sub>3</sub>), 1.52 (s, 6H, 8-<i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 311 (M<sup>+</sup> + 1). Anal. (C<sub>19</sub>H<sub>18</sub>O<sub>4</sub>·<sup>1</sup>/<sub>8</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3′,5′-Dimethyl desmosdumotin B (<b>5</b>)</h4><div class="NLM_p last">Colorless prisms, mp 112−113 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.16 (s, 1H, chelated-O<i>H</i>), 7.38 (s, 2H, 2′- and 6′-<i>H</i>), 7.23 (s, 1H, 4′-<i>H</i>), 6.85 (s, 1H, 3-<i>H</i>), 2.42 (s, 6H, 3′- and 5′-C<i>H</i><sub>3</sub>), 1.88 (s, 3H, 6-C<i>H</i><sub>3</sub>), 1.59 (s, 6H, 8-<i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 325 (M<sup>+</sup> + 1). Anal. (C<sub>20</sub>H<sub>20</sub>O<sub>4</sub>·<sup>1</sup>/<sub>8</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2′,4′,6′-Trimethyl desmosdumotin B (<b>6</b>)</h4><div class="NLM_p last">Colorless prisms, mp 196−197 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.08 (s, 1H, chelated-O<i>H</i>), 6.99 (s, 2H, 3′- and 5′-<i>H</i>), 6.44 (s, 1H, 3-<i>H</i>), 2.36 (s, 3H, 4′-C<i>H</i><sub>3</sub>), 2.22 (s, 6H, 2′- and 6′-C<i>H</i><sub>3</sub>), 1.88 (s, 3H, 6-C<i>H</i><sub>3</sub>), 1.47 (s, 6H, 8-<i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 339 (M<sup>+</sup> + 1). Anal. (C<sub>21</sub>H<sub>22</sub>O<sub>4</sub>·<sup>1</sup>/<sub>4</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4′-Ethyl desmosdumotin B (<b>7</b>)</h4><div class="NLM_p last">Colorless prisms, mp 203−204 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.16 (s, 1H, chelated-O<i>H</i>), 7.72 (d, 2H, <i>J</i> = 8.2 Hz, 2′- and 6′-<i>H</i>), 7.38 (d, 2H, <i>J</i> = 8.2 Hz, 3′- and 5′-<i>H</i>), 6.36 (s, 1H, 3-<i>H</i>), 2.75 (q, 2H, <i>J</i> = 7.4 Hz, 4′-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.88 (s, 3H, 6-C<i>H</i><sub>3</sub>), 1.58 (s, 6H, 8-<i>CH</i><sub>3</sub> × 2), 1.29 (t, 3H, <i>J</i> = 7.4 Hz, 4′-CH<sub>2</sub>C<i>H</i><sub>3</sub>). MS <i>m</i>/<i>z</i>: 323 (M<sup>+</sup> − 1). Anal. (C<sub>20</sub>H<sub>20</sub>O<sub>4</sub>·<sup>1</sup>/<sub>8</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(Naphthalen-1-yl)desmosdumotin B (<b>8</b>)</h4><div class="NLM_p last">Colorless prisms, mp 164−165 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.10 (s, 1H, chelated-O<i>H</i>), 8.87 (d, 1H, <i>J</i> = 8.0 Hz, Ar-<i>H</i>), 8.02−7.94 (m, 2H, A<i>r</i>-<i>H</i>), 7.71−7.67 (m, 1H, A<i>r</i>-<i>H</i>), 7.65−7.58 (m, 3H, A<i>r</i>-<i>H</i>), 6.82 (s, 1H, 3-<i>H</i>), 1.91 (s, 3H, 6-C<i>H</i><sub>3</sub>), 1.54 (s, 6H, 8-<i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 347 (M<sup>+</sup> + 1). Anal. (C<sub>22</sub>H<sub>18</sub>O<sub>4</sub>·<sup>1</sup>/<sub>8</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 6,8,8-Triethyl-7-methoxy desmosdumotin B (<b>40</b>)</h4><div class="NLM_p last">Colorless prisms, mp 131−132 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.78−7.72 (m, 2H, Ar-<i>H</i>), 7.58−7.50 (m, 3H, A<i>r</i>-<i>H</i>), 6.84 (s, 1H, 3-<i>H</i>), 4.01 (s, 3H, 7-O<i>CH</i><sub>3</sub>), 2.58 (q, 2H, <i>J</i> = 7.4 Hz, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.26−2.01 (m, 4H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub> × 2), 1.15 (t, 3H, <i>J</i> = 7.4 Hz, 6-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.71 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 353 (M<sup>+</sup> + 1). Anal. (C<sub>22</sub>H<sub>24</sub>O<sub>4</sub>·<sup>1</sup>/<sub>8</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6,8,8-Tripropyl-7-methoxy desmosdumotin B (<b>46</b>)</h4><div class="NLM_p last">Colorless prisms, mp 124−125 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.78−7.72 (m, 2H, Ar-<i>H</i>), 7.59−7.51 (m, 3H, A<i>r</i>-<i>H</i>), 6.83 (s, 1H, 3-<i>H</i>), 3.99 (s, 3H, 7-O<i>CH</i><sub>3</sub>), 2.54−2.45 (m, 2H, 6-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>), 2.16−1.92 (m, 4H, 8-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> × 2), 1.60−1.46 (m, 2H, 6-CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.21−1.04 (m, 2H, 8- CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.02−0.86 (m, 2H, 8- CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 0.98 (t, 3H, <i>J</i> = 7.4 Hz, 6-CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub><i>3</i></sub>), 0.83 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub><i>3</i></sub> × 2). MS <i>m</i>/<i>z</i>: 395 (M<sup>+</sup>). Anal. (C<sub>25</sub>H<sub>30</sub>O<sub>4</sub>·<sup>1</sup>/<sub>4</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 6-Ethyl-8,8-dimethyl desmosdumotin B (<b>9</b>)</h4><div class="NLM_p last">Method B. 66% two-step overall yield. Pale-yellow prisms, mp 212−213 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.03 (1H, chelated-O<i>H</i>), 7.84−7.78 (m, 2H, 2′- and 6′-<i>H</i>), 7.64−7.53 (m, 3H, 3′-, 4′- and 5′-<i>H</i>), 6.90 (s, 1H, 3-<i>H</i>), 2.44 (q, 2H, <i>J</i> = 7.3 Hz, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.59 (s, 6H, 8-<i>CH</i><sub>3</sub> × 2), 1.04 (t, 3H, <i>J</i> = 7.3 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>). MS <i>m</i>/<i>z</i>: 310 (M<sup>+</sup> − 1). Anal. (C<sub>19</sub>H<sub>18</sub>O<sub>4</sub>) C, H, O.</div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 6,8,8-Triethyl desmosdumotin B (<b>10</b>)</h4><div class="NLM_p last">Method A. 10% yield. Pale-yellow prisms, mp 204−205 °C (CH<sub>2</sub>Cl<sub>2</sub>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.06 (1H, chelated-O<i>H</i>), 7.84−7.77 (m, 2H, 2′- and 6′-<i>H</i>), 7.66−7.54 (m, 3H, 3′-, 4′- and 5′-<i>H</i>), 6.91 (s, 1H, 3-<i>H</i>), 2.46 (q, 2H, <i>J</i> = 7.3 Hz, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.34−2.20 (m, 2H, 8- C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.08−1.94 (m, 2H, 8- C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.05 (t, 3H, <i>J</i> = 7.3 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.68 (t, 6H, <i>J</i> = 7.3 Hz, 8-CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 339 (M<sup>+</sup> + 1). Anal. (C<sub>21</sub>H<sub>22</sub>O<sub>4</sub>·<sup>1</sup>/<sub>4</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6,8,8-Triethyl-4′-methyl desmosdumotin B (<b>11</b>)</h4><div class="NLM_p last">Method B. 55% two-step overall yield. Pale-yellow prisms, mp 182−183 °C (CH<sub>2</sub>Cl<sub>2</sub>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.16 (1H, chelated-O<i>H</i>), 7.70 (d, 2H, <i>J</i> = 8.1 Hz, 2′- and 6′-<i>H</i>), 7.37 (d, 2H, <i>J</i> = 8.1 Hz, 3′- and 5′-<i>H</i>), 6.88 (s, 1H, 3-<i>H</i>), 2.47 (s, 3H, 4′-<i>CH</i><sub>3</sub>), 2.36−2.18 (m, 2H, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.12−1.94 (m, 4H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub> × 2), 1.04 (t, 3H, <i>J</i> = 7.4 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.67 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 351 (M<sup>+</sup> − 1). Anal. (C<sub>22</sub>H<sub>24</sub>O<sub>4</sub>) C, H, O.</div></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6,8,8-Triethyl-4′-ethyl desmosdumotin B (<b>12</b>)</h4><div class="NLM_p last">Method B. 66% two-step overall yield. Colorless prisms, mp 159−160 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.13 (1H, chelated-O<i>H</i>), 7.72 (d, 2H, <i>J</i> = 8.2 Hz, 2′- and 6′-<i>H</i>), 7.39 (d, 2H, <i>J</i> = 8.2 Hz, 3′- and 5′-<i>H</i>), 6.88 (s, 1H, 3-<i>H</i>), 2.75 (q, 4H, <i>J</i> = 7.4 Hz, 4′-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.45 (q, 4H, <i>J</i> = 7.4 Hz, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.36−2.18 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.08−1.94 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.29 (t, 3H, <i>J</i> = 7.4 Hz, 4′-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.04 (t, 3H, <i>J</i> = 7.4 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.67 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 367 (M<sup>+</sup> + 1). Anal. (C<sub>23</sub>H<sub>26</sub>O<sub>4</sub>) C, H, O.</div></div><div id="sec3_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6,8,8-Triethyl-2′-methyl desmosdumotin B (<b>13</b>)</h4><div class="NLM_p last">Method B. 64% two-step overall yield. Pale-yellow prisms, mp 146−147 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.08 (1H, chelated-O<i>H</i>), 7.52−7.42 (m, 2H, Ar-<i>H</i>), 7.40−7.32 (m, Ar-<i>H</i>), 6.62 (s, 1H, 3-<i>H</i>), 2.46 (s, 3H, 2′-<i>CH</i><sub>3</sub>), 2.52−2.42 (m, 2H, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.26−2.13 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.98−1.84 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.04 (t, 3H, <i>J</i> = 7.3 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.67 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 351 (M<sup>+</sup> − 1). Anal. (C<sub>22</sub>H<sub>24</sub>O<sub>4</sub>·<sup>1</sup>/<sub>8</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(Naphthalen-1′-yl)-6,8,8-triethyl desmosdumotin B (<b>14</b>)</h4><div class="NLM_p last">Colorless prisms, mp 185−186 °C (EtOAc−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.07 (1H, chelated-O<i>H</i>), 8.09 (d, 1H, <i>J</i> = 7.9 Hz, Ar-<i>H</i>), 8.02−7.91 (m, 2H, Ar-<i>H</i>), 7.69 (dd, 1H, <i>J</i> = 7.2 and 1.3 Hz, Ar-<i>H</i>), 7.66−7.58 (m, 3H, Ar-<i>H</i>), 6.83 (s, 1H, 3-<i>H</i>), 2.49 (q, 2H, <i>J</i> = 7.4 Hz, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.26−2.12 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.98−1.84 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.07 (t, 3H, <i>J</i> = 7.4 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.73 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). Anal. (C<sub>25</sub>H<sub>24</sub>O<sub>4</sub>) C, H, O.</div></div><div id="sec3_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 6,8,8-Triethyl-2-(phenanthren-9′-yl) desmosdumotin B (<b>15</b>)</h4><div class="NLM_p last">Colorless prisms, mp 184−185 °C (EtOAc−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.07 (1H, chelated-O<i>H</i>), 8.84−8.72 (m, 2H, Ar-<i>H</i>), 8.04−7.94 (m, 1H, Ar-<i>H</i>), 7.98 (s, 1H, Ar-<i>H</i>), 7.92−7.62 (m, 5H, Ar-<i>H</i>), 6.89 (s, 1H, 3-<i>H</i>), 2.49 (q, 2H, <i>J</i> = 7.4 Hz, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.24−2.12 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.97−1.83 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.07 (t, 3H, <i>J</i> = 7.4 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.75 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). Anal. (C<sub>2</sub>H<sub>26</sub>O<sub>4</sub>·<sup>1</sup>/<sub>2</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6,8,8-Tripropyl desmosdumotin B (<b>16</b>)</h4><div class="NLM_p last">Method B. 75% two-step overall yield. Pale-yellow prisms, mp 115−116 °C (CH<sub>2</sub>Cl<sub>2</sub>−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.04 (1H, chelated-O<i>H</i>), 7.82−7.78 (m, 2H, 2′- and 6′-<i>H</i>), 7.64−7.54 (m, 3H, 3′, 4′ and 5′-<i>H</i>), 6.90 (s, 1H, 3-<i>H</i>), 2.44−2.36 (m, 2H, 6-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>), 2.26−2.14 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>), 2.36−2.18 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>3</sub>), 1.54−1.41 (m, 2H, 6-CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.21−1.04 (m, 2H, 8-CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.01−0.84 (m, 2H, 8-CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>3</sub>), 0.95 (t, 3H, <i>J</i> = 7.3 Hz, 6 6-CH<sub>2</sub>CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.79 (t, 6H, <i>J</i> = 7.8 Hz, 8-CH<sub>2</sub>CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). MS <i>m</i>/<i>z</i>: 379 (M<sup>+</sup> − 1). Anal. (C<sub>24</sub>H<sub>26</sub>O<sub>4</sub>) C, H, O.</div></div><div id="sec3_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6,8,8-Triethyl-5-hydroxy-3-phenyl-4H-chromene-4,7(8H)-dione (<b>33</b>)</h4><div class="NLM_p last">Colorless prisms, mp 146−147 °C (EtOAc−hexane). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 13.09 (1H, chelated-O<i>H</i>), 8.08 (s, 1H, 2-<i>H</i>), 7.56−7.44 (m, 5H, Ar-<i>H</i>), 2.46 (q, 2H, <i>J</i> = 7.4 Hz, 6-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.25−2.14 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.00−1.89 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.04 (t, 3H, <i>J</i> = 7.4 Hz, 6-CH<sub>2</sub><i>CH</i><sub>3</sub>), 0.67 (t, 6H, <i>J</i> = 7.4 Hz, 8-CH<sub>2</sub><i>CH</i><sub>3</sub> × 2). Anal. (C<sub>21</sub>H<sub>22</sub>O<sub>4</sub>·<sup>1</sup>/<sub>4</sub>H<sub>2</sub>O) C, H, O.</div></div><div id="sec3_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6,8-Diethyl-2-(4-ethylphenyl)-5,7-dihydroxychromen-4-one (<b>48</b>)</h4><div class="NLM_p last">Pale-yellow powder, mp 263−264 °C (CH<sub>2</sub>Cl<sub>2</sub>−MeOH). <sup>1</sup>H NMR (300 MHz, 10% CD<sub>3</sub>OD in CDCl<sub>3</sub>) δ: 7.83 (d, 2H, <i>J</i> = 8.2 Hz, 2′- and 6′-<i>H</i>), 7.36 (d, 2H, <i>J</i> = 8.2 Hz, 3′- and 5′-<i>H</i>), 6.66 (s, 1H, 3-<i>H</i>), 2.91 (q, 2H, <i>J</i> = 7.3 Hz, 4′-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 2.80−2.66 (m, 4H, 6- and 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.35−1.22 (m, 6H, 6- and 8-CH<sub>2</sub><i>CH</i><sub>3</sub>), 1.18 (t, 3H, <i>J</i> = 7.3 Hz, 4′-CH<sub>2</sub><i>CH</i><sub>3</sub>). MS <i>m</i>/<i>z</i>: 338 (M<sup>+</sup>). Anal. (C<sub>21</sub>H<sub>22</sub>O<sub>4</sub>) C, H, O.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Cytotoxic Activity Assay</h3><div class="NLM_p last">All stock cultures were grown in T-25 flasks. Freshly trypsinized cell suspensions were seeded in 96-well microtiter plates at densities of 1500−7500 cells per well with compounds added from DMSO-diluted stock. After 3 days in culture, attached cells were fixed with cold 50% trichloroacetic acid and then stained with 0.4% sulforhodamine B. The absorbency at 562 nm was measured using a microplate reader after solubilizing the bound dye. The mean ED<sub>50</sub> is the concentration of agent that reduces cell growth by 50% under the experimental conditions and is the average from at least three independent determinations that were reproducible and statistically significant. For the verapamil reversal experiments, cells were cotreated with verapamil (1 µg/mL). Control experiments showed this concentration had no effect on the replication of KB-VIN cells. The following human tumor cell lines were used in the assay: A549 (human lung carcinoma), MCF-7 (breast cancer), HCT-8 (colon adenocarcinoma), PC-3 (prostate cancer), KB (nasopharyngeal carcinoma), and KB-VIN (vincristine-resistant KB subline). All cell lines were obtained from Lineberger Cancer Center (UNC-CH) or from ATCC (Rockville, MD), except KB-VIN which was a generous gift of Professor Y.-C. Cheng, Yale University. Cells were cultured in RPMI-1640 medium supplemented with 25 mM HEPES, 0.25% sodium bicarbonate, 10% fetal bovine serum, and 100 µg/mL kanamycin.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="note1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/jm701208v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data for compounds <b>3−16</b>, <b>33</b>, <b>40</b>, <b>46</b>, and <b>48</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701208v/suppl_file/jm701208v-file008.pdf">jm701208v-file008.pdf (12.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701208v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyoko Nakagawa-Goto</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#93f4fce7fcd3f6fef2faffbde6fdf0bdf6f7e6b3f8f6fdccf1f2e0e7fce4d3e6fdf0bdf6f7e6b3f8fbfff6f6d3e6fdf0bdf6f7e6"><span class="__cf_email__" data-cfemail="d0b7bfa4bf90b5bdb1b9bcfea5beb3feb5b4a5">[email protected]</span> <span class="__cf_email__" data-cfemail="670c0209380506141308102712090449020312">[email protected]</span> <span class="__cf_email__" data-cfemail="73181b1f161633061d105d161706">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth F. Bastow</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a3c4ccd7cce3c6cec2cacf8dd6cdc08dc6c7d683c8c6cdfcc1c2d0d7ccd4e3d6cdc08dc6c7d683c8cbcfc6c6e3d6cdc08dc6c7d6"><span class="__cf_email__" data-cfemail="1f78706b705f7a727e7673316a717c317a7b6a">[email protected]</span> <span class="__cf_email__" data-cfemail="472c2229182526343328300732292469222332">[email protected]</span> <span class="__cf_email__" data-cfemail="f59e9d999090b5809b96db909180">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuo-Hsiung Lee</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97f0f8e3f8d7f2faf6fefbb9e2f9f4b9f2f3e2b7fcf2f9c8f5f6e4e3f8e0d7e2f9f4b9f2f3e2b7fcfffbf2f2d7e2f9f4b9f2f3e2"><span class="__cf_email__" data-cfemail="81e6eef5eec1e4ece0e8edaff4efe2afe4e5f4">[email protected]</span> <span class="__cf_email__" data-cfemail="afc4cac1f0cdcedcdbc0d8efdac1cc81cacbda">[email protected]</span> <span class="__cf_email__" data-cfemail="c9a2a1a5acac89bca7aae7acadbc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tzu-Hsuan Chen</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan L. Morris-Natschke</span> - <span class="hlFld-Affiliation affiliation">Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by grant CA-17625 from the National Cancer Institute, NIH, awarded to K.H.L.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span> </span><span class="NLM_article-title">Strategies for reversing drug resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7512-7523&author=T.+Fojoauthor=S.+Bates&title=Strategies+for+reversing+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%26atitle%3DStrategies%2520for%2520reversing%2520drug%2520resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7512%26epage%3D7523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span> </span><span class="NLM_article-title">Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1111%2Fj.1349-7006.2003.tb01345.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=12708468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2003&pages=15-21&author=T.+Tsuruoauthor=M.+Naitoauthor=A.+Tomidaauthor=N.+Fujitaauthor=T.+Mashimaauthor=H.+Sakamoto&title=Molecular+targeting+therapy+of+cancer%3A+drug+resistance%2C+apoptosis+and+survival+signal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal</span></div><div class="casAuthors">Tsuruo, Takashi; Naito, Mikihiko; Tomida, Akihiro; Fujita, Naoya; Mashima, Tetsuo; Sakamoto, Hiroshi; Haga, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">A review.  Recent progress in the development of mol. cancer therapeutics has revealed new types of antitumor drugs, such as Herceptin, Gleevec, and Iressa, as potent therapeutics for specific tumors.  Our work has focused on mol. cancer therapeutics, mainly in the areas of drug resistance, apoptosis and apoptosis resistance, and survival-signaling, which is related to drug resistance.  In this review, we describe our research on mol. cancer therapeutics, including mol. mechanisms and therapeutic approaches.  Resistance to chemotherapeutic drugs is a principal problem in the treatment of cancer.  P-Glycoprotein (P-gp), encoded by the MDR1 gene, is a multidrug transporter and has a major role in multidrug resistance (MDR).  Targeting of P-gp by small-mol. compds. and/or antibodies is an effective strategy to overcome MDR in cancer, esp. hematol. malignancies.  Several P-gp inhibitors have been developed and are currently under clin. phased studies.  In addn. to the multi-drug transporter proteins, cancer cells have several drug resistance mechanisms.  Solid tumors are often placed under stress conditions, such as glucose starvation and hypoxia.  These conditions result in topo II poison resistance that is due to proteasome-mediated degrdn. of DNA topoisomerases.  Proteasome inhibitors effectively prevent this stress-induced drug resistance.  Glyoxalase I, which is often elevated in drug- and apoptosis-resistant cancers, offers another possibility for overcoming drug resistance.  It plays a role in detoxification of methylglioxal, a side product of glycolysis, which is highly reactive with DNA and proteins.  Inhibitors of glyoxalase I selectively kill drug-resistant tumors that express glyoxalase I.  Finally, the susceptibility of tumor cells to apoptosis induced by antitumor drugs appears to depend on the balance between pro-apoptotic and survival (anti-apoptotic) signals.  PI3K-Akt is an important survival signal pathway, that has been shown to be the target of various antitumor drugs, including UCN-01 and geldanamycin, new anticancer drugs under clin. evaluation.  Our present studies provide novel targets for future effective mol. cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVV4UtvIrFULVg90H21EOLACvtfcHk0lhnxU4ihU4DdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFektLY%253D&md5=c7c87d1ccace5c57183ece07013dfe16</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2003.tb01345.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2003.tb01345.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DTomida%26aufirst%3DA.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DMashima%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26atitle%3DMolecular%2520targeting%2520therapy%2520of%2520cancer%253A%2520drug%2520resistance%252C%2520apoptosis%2520and%2520survival%2520signal%26jtitle%3DCancer%2520Sci.%26date%3D2003%26volume%3D94%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ambudkar, S. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimchi-Sarfaty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauna, Z. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">P-glycoprotein: from genomics to mechanism</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7468</span><span class="NLM_x">–</span> <span class="NLM_lpage">7485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7468-7485&author=S.+V+Ambudkarauthor=C.+Kimchi-Sarfatyauthor=Z.+E.+Saunaauthor=M.+M.+Gottesman&title=P-glycoprotein%3A+from+genomics+to+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbudkar%26aufirst%3DS.%2BV%26aulast%3DKimchi-Sarfaty%26aufirst%3DC.%26aulast%3DSauna%26aufirst%3DZ.%2BE.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DP-glycoprotein%253A%2520from%2520genomics%2520to%2520mechanism%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7468%26epage%3D7485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Leonard, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span> </span><span class="NLM_article-title">The role of ABC transporters in clinical practice</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1634%2Ftheoncologist.8-5-411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=14530494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=411-424&author=G.+D.+Leonardauthor=T.+Fojoauthor=S.+Bates&title=The+role+of+ABC+transporters+in+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ABC transporters in clinical practice</span></div><div class="casAuthors">Leonard, Gregory D.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  Drug resistance remains one of the primary causes of suboptimal outcomes in cancer therapy.  ATP-binding cassette (ABC) transporters are a family of transporter proteins that contribute to drug resistance via ATP-dependent drug efflux pumps.  P-glycoprotein (P-gp), encoded by the MDR1 gene, is an ABC transporter normally involved in the excretion of toxins from cells.  It also confers resistance to certain chemotherapeutic agents.  P-gp is overexpressed at baseline in chemotherapy-resistant tumors, such as colon and kidney cancers, and is upregulated after disease progression following chemotherapy in malignancies such as leukemia and breast cancer.  Other transporter proteins mediating drug resistance include those in the multidrug-resistance-assocd. protein (MRP) family, notably MRP1, and ABCG2.  These transporters are also involved in normal physiol. functions.  The expressions of MRP family members and ABCG2 were not well worked out in cancer.  Increased drug accumulation and drug resistance reversal with P-gp inhibitors were well documented in vitro, but only suggested in clin. trials.  Limitations in the design of early resistance reversal trials contributed to disappointing results.  Despite this, 3 randomized trials have shown statistically significant benefits with the use of a P-gp inhibitor in combination with chemotherapy.  Improved diagnostic techniques aimed at the selection of patients with tumors that express P-gp should result in more successful outcomes.  Further optimism is warranted with the advent of potent, nontoxic inhibitors and new treatment strategies, including the combination of new targeted therapies with therapies aimed at the prevention of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr317MZ9jawCbVg90H21EOLACvtfcHk0lhcl9hf6U5Y8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D&md5=b474f45fd5c45962acfff61840c04a6b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.8-5-411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.8-5-411%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DG.%2BD.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520ABC%2520transporters%2520in%2520clinical%2520practice%26jtitle%3DOncologist%26date%3D2003%26volume%3D8%26spage%3D411%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer, role of ATP-dependent transporter</span> <span class="citation_source-journal">Nat. Rev. Can.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%2C+role+of+ATP-dependent+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lhcl9hf6U5Y8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%252C%2520role%2520of%2520ATP-dependent%2520transporter%26jtitle%3DNat.%2520Rev.%2520Can.%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druley, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">From MDR to MXR: new understanding of multidrug resistance system, their properties in clinical significance</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1007%2FPL00000912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11497241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=931-959&author=T.+Litmanauthor=T.+E.+Druleyauthor=W.+D.+Steinauthor=S.+E.+Bates&title=From+MDR+to+MXR%3A+new+understanding+of+multidrug+resistance+system%2C+their+properties+in+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance</span></div><div class="casAuthors">Litman, T.; Druley, T. E.; Stein, W. D.; Bates, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">931-959</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review, with 235 refs.  The ATP binding cassette (ABC) superfamily of membrane transporters is one of the largest protein classes known, and counts numerous proteins involved in the trafficking of biol. mols. across cell membranes.  The first known human ABC transporter was P-glycoprotein (P-gp), which confers multidrug resistance (MDR) to anticancer drugs.  In recent years, we have obtained an increased understanding of the mechanism of action of P-gp as its ATPase activity, substrate specificity and pharmacokinetic interactions have been investigated.  This review focuses on the functional characterization of P-gp, as well as other ABC transporters involved in MDR: the family of multidrug-resistance-assocd. proteins (MRP1-7), and the recently discovered ABC half-transporter MXR (also known as BCRP, ABCP and ABCG2).  We describe recent progress in the anal. of protein structure-function relationships, and consider the conceptual problem of defining and identifying substrates and inhibitors of MDR.  An in-depth discussion follows of how coupling of nucleotide hydrolysis to substrate transport takes place, and we propose a scheme for the mechanism of P-gp function.  Finally, the clin. correlations, both for reversal of MDR in cancer and for drug delivery, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWgL9Rzpb_qLVg90H21EOLACvtfcHk0ljdo1FajgnQyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSms74%253D&md5=0beeb6d215da60fbdec088848fde9831</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2FPL00000912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00000912%26sid%3Dliteratum%253Aachs%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DDruley%26aufirst%3DT.%2BE.%26aulast%3DStein%26aufirst%3DW.%2BD.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DFrom%2520MDR%2520to%2520MXR%253A%2520new%2520understanding%2520of%2520multidrug%2520resistance%2520system%252C%2520their%2520properties%2520in%2520clinical%2520significance%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2001%26volume%3D58%26spage%3D931%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sawicka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skierski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, W.</span><span> </span><span class="NLM_article-title">A review of selected antitumor therapeutic agents and reasons for multidrug resistance occurrence</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1211%2F0022357044265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=15324475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlGltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1067-1087&author=M.+Sawickaauthor=M.+Kalinowskaauthor=J.+Skierskiauthor=W.+Lewandowski&title=A+review+of+selected+antitumor+therapeutic+agents+and+reasons+for+multidrug+resistance+occurrence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence</span></div><div class="casAuthors">Sawicka, M.; Kalinowska, M.; Skierski, J.; Lewandowski, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1067-1081</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review with refs.  It is assumed that proteins from the ABC family (i.e., glycoprotein P (Pgp)) and a multidrug resistance assocd. protein (MRP) play a main role in the occurrence of multidrug resistance (MDR) in tumor cells.  Other factors that influence the rise of MDR are mechanisms connected with change in the effectiveness of the glutathione cycle and with decrease in expression of topoisomerases I and II.  The aim of this review is to characterize drugs applied in anti-tumor therapy and to describe the present state of knowledge concerning the mechanisms of MDR occurrence, as well as the pharmacol. agents applied in reducing this phenomenon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNa5Qj6Igj57Vg90H21EOLACvtfcHk0ljdo1FajgnQyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlGltLg%253D&md5=b5e0244957983ed0a30fd3984d1d7ad6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1211%2F0022357044265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357044265%26sid%3Dliteratum%253Aachs%26aulast%3DSawicka%26aufirst%3DM.%26aulast%3DKalinowska%26aufirst%3DM.%26aulast%3DSkierski%26aufirst%3DJ.%26aulast%3DLewandowski%26aufirst%3DW.%26atitle%3DA%2520review%2520of%2520selected%2520antitumor%2520therapeutic%2520agents%2520and%2520reasons%2520for%2520multidrug%2520resistance%2520occurrence%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2004%26volume%3D56%26spage%3D1067%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">The biochemistry of P-glycoprotein-mediated multidrug resistance</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1146%2Fannurev.bi.58.070189.001033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=2570548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADyaL1MXkslSiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1989&pages=137-171&author=J.+A.+Endicottauthor=V.+Ling&title=The+biochemistry+of+P-glycoprotein-mediated+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemistry of P-glycoprotein-mediated multidrug resistance</span></div><div class="casAuthors">Endicott, Jane A.; Ling, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">137-71</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    </div><div class="casAbstract">A review with 192 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTZVaPn5Fj27Vg90H21EOLACvtfcHk0lhFzAPHrF7kIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkslSiu7w%253D&md5=9b848bff38fec4a7b9d2463602f7805c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.58.070189.001033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.58.070189.001033%26sid%3Dliteratum%253Aachs%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DThe%2520biochemistry%2520of%2520P-glycoprotein-mediated%2520multidrug%2520resistance%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1989%26volume%3D58%26spage%3D137%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cole, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, E. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span> </span><span class="NLM_article-title">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+P.+Coleauthor=G.+Bhardwajauthor=J.+H.+Gerlachauthor=J.+E.+Mackieauthor=C.+E.+Grantauthor=K.+C.+Almquistauthor=A.+J+Stewartauthor=E.+U.+Kurzauthor=A.+M.+Duncanauthor=R.+G.+Deeley&title=Overexpression+of+a+transporter+gene+in+a+multidrug-resistant+human+lung+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0lhFzAPHrF7kIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DMackie%26aufirst%3DJ.%2BE.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BJ%26aulast%3DKurz%26aufirst%3DE.%2BU.%26aulast%3DDuncan%26aufirst%3DA.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DOverexpression%2520of%2520a%2520transporter%2520gene%2520in%2520a%2520multidrug-resistant%2520human%2520lung%2520cancer%2520cell%2520line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Borst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnholds, J.</span><span> </span><span class="NLM_article-title">A family of drug transporters: the multidrug resistance-associated proteins</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1093%2Fjnci%2F92.16.1295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=10944550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlektr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1295-1302&author=P.+Borstauthor=R.+Eversauthor=M.+Koolauthor=J.+Wijnholds&title=A+family+of+drug+transporters%3A+the+multidrug+resistance-associated+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A family of drug transporters: The multidrug resistance-associated proteins</span></div><div class="casAuthors">Borst, Piet; Evers, Raymond; Kool, Marcel; Wijnholds, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1295-1302</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 93 refs.  The human multidrug resistance-assocd. protein (MRP) family currently has seven members.  The ability of several of these membrane proteins to transport a wide range of anti-cancer drugs out of cells and their presence in many tumors make them prime suspects in unexplained cases of drug resistance, although proof that they contribute to clin. drug resistance is still lacking.  Recent studies have begun to clarify the function of the MRP family members.  MRPs are org. anion transporters; i.e., they transport anionic drugs, exemplified by methotrexate, and neutral drugs conjugated to acidic ligands, such as glutathione (GSH), glucuronate, or sulfate.  However, MRP1, MRP2, and MRP3 can also cause resistance to neutral org. drugs that are not known to be conjugated to acidic ligands by transporting these drugs together with free GSH.  MRP1 can even confer resistance to arsenite and MRP2 to cisplatin, again probably by transporting these compds. in complexes with GSH.  MRP4 overexpression is assocd. with high-level resistance to the nucleoside analogs 9-(2-phosphonylmethoxyethyl) adenine and azidothymidine, both of which are used as anti-human immunodeficiency virus drugs.  MRPs may, therefore, also have a role in resistance against nucleoside analogs used in cancer chemotherapy.  Mice without Mrp1, a high-affinity leukotriene C4 transporter, have an altered response to inflammatory stimuli but are otherwise healthy and fertile.  MRP2 is the major transporter responsible for the secretion of bilirubin glucuronides into bile, and humans without MRP2 develop a mild liver disease known as the Dubin-Johnson syndrome.  The physiol. functions of the other MRPs are not known.  Whether long-term inhibition of MRPs in humans can be tolerated (assuming that suitable inhibitors will be found) remains to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoI-EICNsS7Vg90H21EOLACvtfcHk0liQPHUz8njF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlektr8%253D&md5=d7b5b6c8f74b1805e61ebfdbf223ad05</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.16.1295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.16.1295%26sid%3Dliteratum%253Aachs%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DKool%26aufirst%3DM.%26aulast%3DWijnholds%26aufirst%3DJ.%26atitle%3DA%2520family%2520of%2520drug%2520transporters%253A%2520the%2520multidrug%2520resistance-associated%2520proteins%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D1295%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Leslie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. P.</span><span> </span><span class="NLM_article-title">Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1016%2FS0300-483X%2801%2900454-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11557126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms12nurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2001&pages=3-23&author=E.+M.+Leslieauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Toxicological+relevance+of+the+multidrug+resistance+protein+1%2C+MRP1+%28ABCC1%29+and+related+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters</span></div><div class="casAuthors">Leslie, E. M.; Deeley, R. G.; Cole, S. P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-23</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The 190 kDa multidrug resistance protein 1 (MRP1/ABCC1) is a founding member of a subfamily of the ATP binding cassette (ABC) superfamily of transport proteins and was originally identified on the basis of its elevated expression in multidrug resistant lung cancer cells.  In addn. to its ability to confer resistance in tumor cells, MRP1 is ubiquitously expressed in normal tissues and is a primary active transporter of GSH, glucuronate and sulfate conjugated and unconjugated org. anions of toxicol. relevance.  Substrates include lipid peroxidn. products, herbicides, tobacco specific nitrosamines, mycotoxins, heavy metals, and natural product and antifolate anti-cancer agents.  MRP1 also transports unmodified xenobiotics but often requires GSH to do so.  Active efflux is generally an important aspect of cellular detoxification since it prevents the accumulation of conjugated and unconjugated compds. that have the potential to be directly toxic.  The related transporters MRP2 and MRP3 have overlapping substrate specificities with MRP1 but different tissue distributions, and evidence that they also have chemoprotective functions are discussed.  Finally, MRP homologs have been described in other species including yeast and nematodes.  Those isolated from the vascular plant Arabidopsis thaliana (AtMRPs) decrease the cytoplasmic concn. of conjugated toxins through sequestration in vacuoles and are implicated in providing herbicide resistance to plants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLK4gAGj-F7Vg90H21EOLACvtfcHk0liQPHUz8njF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms12nurk%253D&md5=2e72d71aeecda11c673d1d63324a7449</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2801%2900454-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252801%252900454-1%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DToxicological%2520relevance%2520of%2520the%2520multidrug%2520resistance%2520protein%25201%252C%2520MRP1%2520%2528ABCC1%2529%2520and%2520related%2520transporters%26jtitle%3DToxicology%26date%3D2001%26volume%3D167%26spage%3D3%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Holland, B.; Cole, S. P. C.; Kuchler, K.; Higgins, C. F.</span>, Eds.  <span class="citation_source-book">ABC Protein from Bacteria to Man</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=B.+Holland&author=S.+P.+C.+Cole&author=K.+Kuchler&author=C.+F.+Higgins&title=ABC+Protein+from+Bacteria+to+Man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DB.%26btitle%3DABC%2520Protein%2520from%2520Bacteria%2520to%2520Man%26pub%3DAcademic%2520Press%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Takara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, K.</span><span> </span><span class="NLM_article-title">An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.2174%2F138161206775201965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=16454744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlCrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=273-286&author=K.+Takaraauthor=T.+Sakaedaauthor=K.+Okumura&title=An+update+on+overcoming+MDR1-mediated+multidrug+resistance+in+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy</span></div><div class="casAuthors">Takara, Kohji; Sakaeda, Toshiyuki; Okumura, Katsuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-286</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The intrinsic or acquired resistance to anticancer drugs remains one of the most significant factors impeding the progress of cancer chemotherapy.  This phenomenon often involves simultaneous resistance to other anticancer drugs that differ in their chem. structure and mode of action and are not even used in chemotherapy.  This phenotype has been called multidrug resistance (MDR).  Although the cellular basis underlying MDR is not fully understood, several factors mediating therapy resistance in tumors have been proposed.  One of the mechanisms leading to chemoresistance of tumor cells is the increased activity of transporter proteins.  The best-characterized transporter protein is MDR1/P-glycoprotein, and a no. of clin. investigations have suggested that its intrinsic or acquired overexpression resulted in a poor clin. outcome of chemotherapy.  Various types of compds. and techniques for the reversal of MDR1/P-glycoprotein-mediated MDR have been developed, and efforts have concd. on the inhibition of function and suppression of expression.  This review summarizes the current state of knowledge of MDR1/P-glycoprotein and the modulation of MDR by targeting MDR1/P-glycoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooxmakl8p8xrVg90H21EOLACvtfcHk0lhUqYsZxp-tiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlCrug%253D%253D&md5=d80dd638eb3b8504785ead7fcf24823b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138161206775201965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775201965%26sid%3Dliteratum%253Aachs%26aulast%3DTakara%26aufirst%3DK.%26aulast%3DSakaeda%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DK.%26atitle%3DAn%2520update%2520on%2520overcoming%2520MDR1-mediated%2520multidrug%2520resistance%2520in%2520cancer%2520chemotherapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D273%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Modok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span> <span class="citation_source-journal">Curr. Opin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1016%2Fj.coph.2006.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=16690355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=350-354&author=S.+Modokauthor=H.+R.+Mellorauthor=R.+Callaghan&title=Modulation+of+multidrug+resistance+efflux+pump+activity+to+overcome+chemoresistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span></div><div class="casAuthors">Modok, Szabolcs; Mellor, Howard R.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-354</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Early publications using cultured cancer cells immediately recognized the phenomenon of resistance to anticancer agents.  However, it was not until 1973 that it was first demonstrated that a major factor in the resistance of cancer cells was that of reduced drug accumulation.  This year marks the 30th anniversary of the discovery by Juliano and Ling that P-glycoprotein mediates this active efflux of chemotherapeutic drugs from cancer cells.  Since this seminal finding, the investigation of P-glycoprotein (MDR1, ATP binding cassette [ABC]B1) has proceeded with great vigour.  However, it soon became apparent that P-glycoprotein was not expressed in all drug-resistant cells that displayed an accumulation deficiency, which led to the discovery of other ABC transporters involved in drug efflux.  In 1992, the multidrug resistance-assocd. protein (MRP1, ABCC1) was identified in small cell lung cancer followed by breast cancer resistance protein (mitoxantrone resistance protein, ABCG2) in 1999.  After three decades of research, can we confidently define the contribution of multidrug resistance transporters to chemoresistance and do we have clin. useful drugs to sensitize cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEJzb35-rDLVg90H21EOLACvtfcHk0lhUqYsZxp-tiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D&md5=9fbe122b53419fa753a006af6840c326</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DModok%26aufirst%3DS.%26aulast%3DMellor%26aufirst%3DH.%2BR.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520efflux%2520pump%2520activity%2520to%2520overcome%2520chemoresistance%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharm.%26date%3D2006%26volume%3D6%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Avendaño, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menéndez, C.</span><span> </span><span class="NLM_article-title">Recent advances in multidrug resistance modulators</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlShtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=419-444&author=C.+Avenda%C3%B1oauthor=C.+Men%C3%A9ndez&title=Recent+advances+in+multidrug+resistance+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in multidrug resistance modulators</span></div><div class="casAuthors">Avendano, Carmen; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Reviews--Online</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-444</span>CODEN:
                <span class="NLM_cas:coden">MCREC9</span>;
        ISSN:<span class="NLM_cas:issn">1567-2034</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a type of resistance to structurally unrelated chemotherapeutic drugs, and is one of the main obstacles in the chemotherapy of cancer, malaria and other diseases.  In the case of cancer, its inhibition by combination of chemosensitizers with antitumor compds. continues to be a very active field of research, since the availability of safe and potent reversal agents would be very beneficial for clin. use.  The discovery of new structures with MDR modulating properties is taking place at a fast pace, together with the clin. evaluation of the most promising of the previously known compds.  Most modulators act by binding to membrane transport proteins (specially P-gp and MRP) and inhibiting their drug-effluxing activity, but some of them act by indirect mechanisms, including inhibition of the expression of the mdr1 gene.  General structure-activity studies of this therapeutic group are hampered by the very heterogeneous chem. structure of the compds., although some conclusions regarding the location of binding domains of P-gp and the structural requirements for MDR reversal have been drawn recently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3nOIpQnmKRbVg90H21EOLACvtfcHk0lhUqYsZxp-tiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlShtLw%253D&md5=1466401899ed12d6e27a18d2d3477617</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvenda%25C3%25B1o%26aufirst%3DC.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520multidrug%2520resistance%2520modulators%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2004%26volume%3D1%26spage%3D419%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lehne, G.</span><span> </span><span class="NLM_article-title">P-glycoprotein as a drug target in the treatment of multidrug resistant cancer</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.2174%2F1389450003349443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11475537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1WhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=85-99&author=G.+Lehne&title=P-glycoprotein+as+a+drug+target+in+the+treatment+of+multidrug+resistant+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein as a drug target in the treatment of multidrug resistant cancer</span></div><div class="casAuthors">Lehne, Gustav</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-99</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 187 refs.  Multidrug resistance (MDR) is a major obstacle to successful cancer chemotherapy.  One important mechanism of MDR involves the multidrug transporter, P-glycoprotein (Pgp), which confers upon cancer cells the ability to resist LDs of certain cytotoxic drugs by pumping the drugs out of the cells and thus reducing their cytotoxicity.  Pgp belongs to the ATP-binding cassette (ABC) family of transporter mols. which require hydrolysis of ATP to run the transport mechanism.  The substrates of Pgp may be endogenous (steroid hormones, cytokines) or exogenous (cytostatic drugs).  A no. of studies have demonstrated a neg. correlation between Pgp expression levels and chemosensitivity or survival in a range of human malignancies.  In principle, Pgp mediated drug resistance can be circumvented by treatment regimens that either exclude Pgp substrate drugs or include Pgp inhibitory agents.  Exptl. studies have demonstrated that certain structural modifications of anthracyclines confer the ability to escape Pgp transport.  The therapeutic benefit of Pgp inhibitors as chemosensitizers is currently being explored in phase III clin. trials, and the first promising results have already been reported.  Another therapeutic option for Pgp inhibitors has recently evolved as several Pgp inhibitors, many of which are generally low-toxic substances, by themselves constrain proliferation and cause cell death by apoptosis in certain MDR cancer cell lines.  The dual effect of Pgp inhibitors, targeting MDR cancer cells selectively, may translate into improved efficacy of cancer chemotherapy and perhaps new and less toxic drug treatment strategies in human MDR cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMLUMMjg9OLVg90H21EOLACvtfcHk0lhNWh8_A5qwng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1WhtLw%253D&md5=64f838819d62e5478e19545c9104cadc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1389450003349443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450003349443%26sid%3Dliteratum%253Aachs%26aulast%3DLehne%26aufirst%3DG.%26atitle%3DP-glycoprotein%2520as%2520a%2520drug%2520target%2520in%2520the%2520treatment%2520of%2520multidrug%2520resistant%2520cancer%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2000%26volume%3D1%26spage%3D85%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baubichon-Cortay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trompier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrotton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span> </span><span class="NLM_article-title">Anticancer multidrug resistance mediated by MRP1: Recent advances in the discovery of reversal agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1002%2Fmed.20032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=15834856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntlSkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=453-472&author=A.+Boumendjelauthor=H.+Baubichon-Cortayauthor=D.+Trompierauthor=T.+Perrottonauthor=A.+Di+Pietro&title=Anticancer+multidrug+resistance+mediated+by+MRP1%3A+Recent+advances+in+the+discovery+of+reversal+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents</span></div><div class="casAuthors">Boumendjel, Abcene; Baubichon-Cortay, Helene; Trompier, Doriane; Perrotton, Thomas; Di Pietro, Attilio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-472</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance protein 1 (MRP1) belongs to the ATP-binding cassette (ABC) transporter family.  It is able to transport a broad range of anticancer drugs through cellular membranes, thus limiting their antiproliferative action.  Since its discovery in 1992, MRP1 has been the most studied among MRP proteins, which now count nine members.  Besides the biol. work, which targets structure elucidation, binding sites location, and mode of action, most efforts have been focused on finding mols. which act as MRP1 inhibitors.  In this review, we attempt to summarize and highlight studies dealing with modulators of MRP1-mediated multidrug resistance (MDR), which have been accomplished in the last 5 years.  The reported MRP1 inhibitors are discussed according to their chem. class.  Finally, we try to bring information on structure-activity relationship (SAR) aspects and how modulators might interact with MRP1.  This study may facilitate the rational design of future modulators of MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr85--UhePH0rVg90H21EOLACvtfcHk0lhNWh8_A5qwng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntlSkur8%253D&md5=3ee3289b71a2f12660dbd0d10b0038c2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmed.20032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20032%26sid%3Dliteratum%253Aachs%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DTrompier%26aufirst%3DD.%26aulast%3DPerrotton%26aufirst%3DT.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DAnticancer%2520multidrug%2520resistance%2520mediated%2520by%2520MRP1%253A%2520Recent%2520advances%2520in%2520the%2520discovery%2520of%2520reversal%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D453%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mavel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palakas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emond, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greguric, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrigos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilloteau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsifis, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABBCC1/MRP1)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1599-1607&author=S.+Mavelauthor=B.+Dikicauthor=S.+Palakasauthor=P.+Emondauthor=I.+Greguricauthor=A.+G.+Graciaauthor=F.+Mattnerauthor=M.+Garrigosauthor=D.+Guilloteauauthor=A.+Katsifis&title=Synthesis+and+biological+evaluation+of+a+series+of+flavone+derivatives+as+potential+radioligands+for+imaging+the+multidrug+resistance-associated+protein+1+%28ABBCC1%2FMRP1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMavel%26aufirst%3DS.%26aulast%3DDikic%26aufirst%3DB.%26aulast%3DPalakas%26aufirst%3DS.%26aulast%3DEmond%26aufirst%3DP.%26aulast%3DGreguric%26aufirst%3DI.%26aulast%3DGracia%26aufirst%3DA.%2BG.%26aulast%3DMattner%26aufirst%3DF.%26aulast%3DGarrigos%26aufirst%3DM.%26aulast%3DGuilloteau%26aufirst%3DD.%26aulast%3DKatsifis%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520series%2520of%2520flavone%2520derivatives%2520as%2520potential%2520radioligands%2520for%2520imaging%2520the%2520multidrug%2520resistance-associated%2520protein%25201%2520%2528ABBCC1%252FMRP1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1599%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietro, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barron, D.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1002%2Fmed.10015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=12210557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFSls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=512-529&author=A.+Boumendjelauthor=A.+D.+Pietroauthor=C.+Dumontetauthor=D.+Barron&title=Recent+advances+in+the+discovery+of+flavonoids+and+analogs+with+high-affinity+binding+to+P-glycoprotein+responsible+for+cancer+cell+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance</span></div><div class="casAuthors">Boumendjel, Ahcene; Di Pietro, Attilio; Dumontet, Charles; Barron, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">512-529</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  P-glycoprotein (P-gp) is a plasma membrane glycoprotein that confers multidrug resistance on cells by virtue of its ability to exclude cytotoxic drugs in an ATP-dependent manner.  The most commonly considered hypothesis is that P-gp acts as an ATP-driven drug-export pump, the mechanism of which is not understood in detail.  Therefore, a tremendous effort is being made to find out modulator mols. to inhibit P-gp.  The authors have been developing flavonoid derivs. as a new class of promising modulators using a new in vitro rational-screening assay based on measurements of the binding-affinity toward the C-terminal nucleotide-binding domain (NBD2) of P-gp.  This review is focused on the authors' results obtained with a variety of flavonoids.  Structure-activity relationships of flavonoids as potential MDR modulators are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Hsu32gRSf7Vg90H21EOLACvtfcHk0lhlXem5jn3Hqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFSls78%253D&md5=9a2f7acacf9e9997769b8331dbce10b1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fmed.10015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10015%26sid%3Dliteratum%253Aachs%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DPietro%26aufirst%3DA.%2BD.%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DBarron%26aufirst%3DD.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520flavonoids%2520and%2520analogs%2520with%2520high-affinity%2520binding%2520to%2520P-glycoprotein%2520responsible%2520for%2520cancer%2520cell%2520multidrug%2520resistance%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2002%26volume%3D22%26spage%3D512%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conseil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baubichon-Cortay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jault, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daskiewicz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietro, A. D.</span><span> </span><span class="NLM_article-title">Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein: Structure−activity relationships for flavonoid binding</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10382</span><span class="NLM_x">–</span> <span class="NLM_lpage">10391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10382-10391&author=H.+Wetauthor=D.+B.+McIntoshauthor=G.+Conseilauthor=H.+Baubichon-Cortayauthor=T.+Krellauthor=J.+M.+Jaultauthor=J.+B.+Daskiewiczauthor=D.+Barronauthor=A.+D.+Pietro&title=Sequence+requirements+of+the+ATP-binding+site+within+the+C-terminal+nucleotide-binding+domain+of+mouse+P-glycoprotein%3A+Structure%E2%88%92activity+relationships+for+flavonoid+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWet%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DD.%2BB.%26aulast%3DConseil%26aufirst%3DG.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DKrell%26aufirst%3DT.%26aulast%3DJault%26aufirst%3DJ.%2BM.%26aulast%3DDaskiewicz%26aufirst%3DJ.%2BB.%26aulast%3DBarron%26aufirst%3DD.%26aulast%3DPietro%26aufirst%3DA.%2BD.%26atitle%3DSequence%2520requirements%2520of%2520the%2520ATP-binding%2520site%2520within%2520the%2520C-terminal%2520nucleotide-binding%2520domain%2520of%2520mouse%2520P-glycoprotein%253A%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520flavonoid%2520binding%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10382%26epage%3D10391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z. W.</span><span> </span><span class="NLM_article-title">Desmosdumotin B: A new special flavone from <i>Desmos dumosus</i></span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=49-50&author=J.-H.+Wuauthor=S.+L.+Maoauthor=S.+X.+Liaoauthor=Y.+H.+Yiauthor=C.+Q.+Lanauthor=Z.+W.+Su&title=Desmosdumotin+B%3A+A+new+special+flavone+from+Desmos+dumosus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Desmosdumotin B: a new special flavone from Desmos dumosus</span></div><div class="casAuthors">Wu, Jiu Hong; Mao, Shi Long; Liao, Shi Xuan; Yi, Yang Hua; Lan, Chuan Qing; Su, Zhong Wu</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-50</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Chinese Chemical Society</span>)
        </div><div class="casAbstract">A new special flavone, named desmosdumotin B, was isolated from the roots of D. dumosus and its chem. structure identified as 5-hydroxy-7-one-6,8,8-trimethylflavone by spectral anal. and X-ray (no data).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo091Aus2m8DrVg90H21EOLACvtfcHk0lhlXem5jn3Hqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlWktro%253D&md5=2d2ff6413a499c5c918be111fb8a7d16</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DMao%26aufirst%3DS.%2BL.%26aulast%3DLiao%26aufirst%3DS.%2BX.%26aulast%3DYi%26aufirst%3DY.%2BH.%26aulast%3DLan%26aufirst%3DC.%2BQ.%26aulast%3DSu%26aufirst%3DZ.%2BW.%26atitle%3DDesmosdumotin%2520B%253A%2520A%2520new%2520special%2520flavone%2520from%2520Desmos%2520dumosus%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D12%26spage%3D49%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wu, J.-H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Junko</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span> </span><span class="NLM_article-title">Desmosdumotin C, a novel cytotoxic principle from <i>Desmos dumosus</i></span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1391</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1391-1393&author=J.-H+Wuauthor=A.+T.+McPhailauthor=K.+F.+Bastowauthor=H.+Shirakiauthor=Junko+Itoauthor=K.-H.+Lee&title=Desmosdumotin+C%2C+a+novel+cytotoxic+principle+from+Desmos+dumosus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-H%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DShiraki%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DJunko%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DDesmosdumotin%2520C%252C%2520a%2520novel%2520cytotoxic%2520principle%2520from%2520Desmos%2520dumosus%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D1391%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3016</span><span class="NLM_x">–</span> <span class="NLM_lpage">3019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3016-3019&author=K.+Nakagawa-Gotoauthor=K.+F.+Bastowauthor=J.-H.+Wuauthor=H.+Tokudaauthor=K.+H.+Lee&title=Total+synthesis+and+bioactivity+of+unique+flavone+desmosdumotin+B+and+its+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DTokuda%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DTotal%2520synthesis%2520and%2520bioactivity%2520of%2520unique%2520flavone%2520desmosdumotin%2520B%2520and%2520its%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3016%26epage%3D3019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span> </span><span class="NLM_article-title">First total synthesis of desmosdumotin C</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1081%2FSCC-200063907" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=1-5&author=K.+Nakagawa-Gotoauthor=J.-H+Wuauthor=K.-H.+Lee&title=First+total+synthesis+of+desmosdumotin+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1081%2FSCC-200063907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-200063907%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.-H%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DFirst%2520total%2520synthesis%2520of%2520desmosdumotin%2520C%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents 243. Syntheses and cytotoxicity of desmosdumotin C derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2325-2330&author=K.+Nakagawa-Gotoauthor=J.-H.+Wuauthor=K.+F.+Bastowauthor=C.-C.+Wuauthor=K.+H.+Lee&title=Antitumor+agents+243.+Syntheses+and+cytotoxicity+of+desmosdumotin+C+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DWu%26aufirst%3DC.-C.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents%2520243.%2520Syntheses%2520and%2520cytotoxicity%2520of%2520desmosdumotin%2520C%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2325%26epage%3D2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents 259. Design, syntheses and structure−activity relationship study of desmosdumotin C analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3354</span><span class="NLM_x">–</span> <span class="NLM_lpage">3358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0702534" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3354-3358&author=K.+Nakagawa-Gotoauthor=T.-H.+Chenauthor=C.-Y.+Pengauthor=K.+F.+Bastowauthor=K.+H.+Lee&title=Antitumor+agents+259.+Design%2C+syntheses+and+structure%E2%88%92activity+relationship+study+of+desmosdumotin+C+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0702534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0702534%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DT.-H.%26aulast%3DPeng%26aufirst%3DC.-Y.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents%2520259.%2520Design%252C%2520syntheses%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520of%2520desmosdumotin%2520C%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3354%26epage%3D3358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, G. M.</span><span> </span><span class="NLM_article-title">An efficient “one pot” synthesis of isoflavones</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1080%2F00397910008087343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFemu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=469-484&author=S.+Balasubramanianauthor=G.+M.+Nair&title=An+efficient+%E2%80%9Cone+pot%E2%80%9D+synthesis+of+isoflavones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient "one pot" synthesis of isoflavones</span></div><div class="casAuthors">Balasubramanian, Sreenivasan; Nair, Muraleedharan G.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-484</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Initial formation of deoxybenzoins from 4-RC6H4CH2CO2H (R = H, HO, MeO) 3,4,5-R1R2R3C6H2OH (R1 = HO, MeO, H; R2 = H, HO; R3 = H, HO) in the presence of BF3.Et2O followed by its treatment at room temp. with N,N'-dimethyl(chloromethylene)ammonium chloride, generated by reacting PCl5 with DMF provides a mild and efficient route for a "one pot" synthesis of isoflavones I in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJU9tNGRsP_7Vg90H21EOLACvtfcHk0lhipWnFYQWZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFemu7w%253D&md5=d9ddab8d85f350e09bce5a789039c753</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00397910008087343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008087343%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DG.%2BM.%26atitle%3DAn%2520efficient%2520%25E2%2580%259Cone%2520pot%25E2%2580%259D%2520synthesis%2520of%2520isoflavones%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D469%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><div class="note"><p class="first last">2,6-Dimethyl-DesB showed similar activity and selectivity against KB and KB-VIN to 2,4,6-trimethyl-DesB (<b>6</b>), although the data were not shown because of the low yield and difficulty of purification of this compound</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2%2C6-Dimethyl-DesB+showed+similar+activity+and+selectivity+against+KB+and+KB-VIN+to+2%2C4%2C6-trimethyl-DesB+%286%29%2C+although+the+data+were+not+shown+because+of+the+low+yield+and+difficulty+of+purification+of+this+compound."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagakura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarui, S.</span><span> </span><span class="NLM_article-title">Pharmacogenomics of drug transporters: a new approach to functional analysis of ABCB1 (P-glycoprotein/MDR1)</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1248%2Fbpb.27.939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=15256718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFKku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=939-948&author=T.+Ishikawaauthor=Y.+Onishiauthor=H.+Hiranoauthor=K.+Oosumiauthor=M.+Nagakuraauthor=S.+Tarui&title=Pharmacogenomics+of+drug+transporters%3A+a+new+approach+to+functional+analysis+of+ABCB1+%28P-glycoprotein%2FMDR1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of drug transporters: A new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1)</span></div><div class="casAuthors">Ishikawa, Toshihisa; Onishi, Yuko; Hirano, Hiroyuki; Oosumi, Keisuke; Nagakura, Makoto; Tarui, Shigeki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">939-948</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  In the 21st century, emerging genomic technologies (i.e., bioinformatics, functional genomics, and pharmacogenomics) are shifting the paradigm of drug discovery research and improving the strategy of medical care for patients.  In order to realize the personalized medicine, it is critically important to understand mol. mechanisms underlying inter-individual differences in the drug response, namely, pharmacol. effect vs. side effect.  Evidence is now accumulating to strongly suggest that drug transporters are one of the determinant factors governing the pharmacokinetic profile of drugs.  Effort has been made to identify genetic variation in drug transporter genes.  In particular, genetic variations of the human ABCB1 (P-glycoprotein/MDR1) gene have been most extensively studied.  Hitherto more than fifty single nucleotide polymorphisms (SNPs) and insertion/deletion polymorphisms in the ABCB1 gene have been reported.  However, at the present time, information is still limited with respect to the actual effect of those genetic polymorphisms on the function of ABCB1.  In this context, we have undertaken functional analyses of ABCB1 polymorphisms.  To quantify the impact of genetic polymorphisms on the substrate specificity of ABCB1, we have developed a high-speed screening system and a new structure-activity relationship (SAR) anal. method.  This review addresses functional aspects of the genetic polymorphism of ABCB1 and provides the std. method to evaluate the effect of polymorphisms on the function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRupwwVS1JdbVg90H21EOLACvtfcHk0lhUZuMd9ifPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFKku7k%253D&md5=4f1182f0dac18c7465e186d7e9196ce8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1248%2Fbpb.27.939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.27.939%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DOnishi%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DH.%26aulast%3DOosumi%26aufirst%3DK.%26aulast%3DNagakura%26aufirst%3DM.%26aulast%3DTarui%26aufirst%3DS.%26atitle%3DPharmacogenomics%2520of%2520drug%2520transporters%253A%2520a%2520new%2520approach%2520to%2520functional%2520analysis%2520of%2520ABCB1%2520%2528P-glycoprotein%252FMDR1%2529%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2004%26volume%3D27%26spage%3D939%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kimchi-Sarfaty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauna, Z. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calcagno, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">A “silent” polymorphism in the MDR1 gene changes substrate specificity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=525-528&author=C.+Kimchi-Sarfatyauthor=J.+M.+Ohauthor=I.+W.+Kimauthor=Z.+E.+Saunaauthor=A.+M.+Calcagnoauthor=S.+V.+Ambudkarauthor=M.+M.+Gottesman&title=A+%E2%80%9Csilent%E2%80%9D+polymorphism+in+the+MDR1+gene+changes+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimchi-Sarfaty%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DI.%2BW.%26aulast%3DSauna%26aufirst%3DZ.%2BE.%26aulast%3DCalcagno%26aufirst%3DA.%2BM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DA%2520%25E2%2580%259Csilent%25E2%2580%259D%2520polymorphism%2520in%2520the%2520MDR1%2520gene%2520changes%2520substrate%2520specificity%26jtitle%3DScience%26date%3D2007%26volume%3D26%26spage%3D525%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span> </span><span class="NLM_article-title">The NCI60 human tumour cell line anticancer drug screen</span> <span class="citation_source-journal">Nature Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1038%2Fnrc1951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=813-823&author=R.+H.+Shoemaker&title=The+NCI60+human+tumour+cell+line+anticancer+drug+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The NCI60 human tumour cell line anticancer drug screen</span></div><div class="casAuthors">Shoemaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-823</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The US National Cancer Institute (NCI) 60 human tumor cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumors in anticancer drug screening.  This screening model was rapidly recognized as a rich source of information about the mechanisms of growth inhibition and tumor-cell kill.  Recently, its role has changed to that of a service screen supporting the cancer research community.  The author reviews the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ysyTSc1-p7Vg90H21EOLACvtfcHk0lhUZuMd9ifPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D&md5=c6c1a074b9dc7e138f45734499769284</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrc1951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1951%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520NCI60%2520human%2520tumour%2520cell%2520line%2520anticancer%2520drug%2520screen%26jtitle%3DNature%2520Rev.%26date%3D2006%26volume%3D6%26spage%3D813%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauna, Z. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fales, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4808</span><span class="NLM_x">–</span> <span class="NLM_lpage">4815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1158%2F0008-5472.CAN-05-3322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=16651436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4808-4815&author=J.+A.+Ludwigauthor=G.+Szak%C3%A1csauthor=S.+E.+Martinauthor=B.+F.+Chuauthor=C.+Cardarelliauthor=Z.+E.+Saunaauthor=N.+J.+Caplenauthor=H.+M.+Falesauthor=S.+V.+Ambudkarauthor=J.+N.+Weinsteinauthor=M.+M.+Gottesman&title=Selective+toxicity+of+NSC73306+in+MDR1-positive+cells+as+a+new+strategy+to+circumvent+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in Cancer</span></div><div class="casAuthors">Ludwig, Joseph A.; Szakacs, Gergely; Martin, Scott E.; Chu, Benjamin F.; Cardarelli, Carol; Sauna, Zuben E.; Caplen, Natasha J.; Fales, Henry M.; Ambudkar, Suresh V.; Weinstein, John N.; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4808-4815</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ATP-binding cassette (ABC) proteins include the best known mediators of resistance to anticancer drugs.  In particular, ABCB1 [MDR1/P-glycoprotein (P-gp)] extrudes many types of drugs from cancer cells, thereby conferring resistance to those agents.  Attempts to overcome P-gp-mediated drug resistance using specific inhibitors of P-gp has had limited success and has faced many therapeutic challenges.  As an alternative approach to using P-gp inhibitors, we characterize a thiosemicarbazone deriv. (NSC73306) identified in a generic screen as a compd. that exploits, rather than suppresses, P-gp function to induce cytotoxicity.  Cytotoxic activity of NSC73306 was evaluated in vitro using human epidermoid, ovarian, and colon cancer cell lines expressing various levels of P-gp.  Our findings suggest that cells become hypersensitive to NSC73306 in proportion to the increased P-gp function and multidrug resistance (MDR).  Abrogation of both sensitivity to NSC73306 and resistance to P-gp substrate anticancer agents occurred with specific inhibition of P-gp function using either a P-gp inhibitor (PSC833, XR9576) or RNA interference, suggesting that cytotoxicity was linked to MDR1 function, not to other, nonspecific factors arising during the generation of resistant or transfected cells.  Mol. characterization of cells selected for resistance to NSC73306 revealed loss of P-gp expression and consequent loss of the MDR phenotype.  Although hypersensitivity to NSC73306 required functional expression of P-gp, biochem. assays revealed no direct interaction between NSC73306 and P-gp.  This article shows that NSC73306 kills cells with intrinsic or acquired P-gp-induced MDR and indirectly acts to eliminate resistance to MDR1 substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOLtC7BqnRW7Vg90H21EOLACvtfcHk0lgCxKHYSS43QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2kt7w%253D&md5=9978857f34af74d365e415a0bd211ad7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3322%26sid%3Dliteratum%253Aachs%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DChu%26aufirst%3DB.%2BF.%26aulast%3DCardarelli%26aufirst%3DC.%26aulast%3DSauna%26aufirst%3DZ.%2BE.%26aulast%3DCaplen%26aufirst%3DN.%2BJ.%26aulast%3DFales%26aufirst%3DH.%2BM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DSelective%2520toxicity%2520of%2520NSC73306%2520in%2520MDR1-positive%2520cells%2520as%2520a%2520new%2520strategy%2520to%2520circumvent%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4808%26epage%3D4815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyoko  Nakagawa-Goto</span>, <span class="hlFld-ContribAuthor ">Akifumi  Oda</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Emika  Ohkoshi</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, and <span class="hlFld-ContribAuthor ">Masuo  Goto</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Novel Class of Tubulin Inhibitor from Desmosdumotin B with a Hydroxylated Bicyclic B-Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (5)
                                     , 2378-2389. <a href="https://doi.org/10.1021/jm501859j" title="DOI URL">https://doi.org/10.1021/jm501859j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501859j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501859j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BNovel%252BClass%252Bof%252BTubulin%252BInhibitor%252Bfrom%252BDesmosdumotin%252BB%252Bwith%252Ba%252BHydroxylated%252BBicyclic%252BB-Ring%26aulast%3DNakagawa-Goto%26aufirst%3DKyoko%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D02122014%26date%3D26022015%26date%3D12032015%26date%3D19022015%26volume%3D58%26issue%3D5%26spage%3D2378%26epage%3D2389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gergely  Szakács</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hall</span>, <span class="hlFld-ContribAuthor ">Michael M.  Gottesman</span>, <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>, <span class="hlFld-ContribAuthor ">Remy  Kachadourian</span>, <span class="hlFld-ContribAuthor ">Brian J.  Day</span>, <span class="hlFld-ContribAuthor ">Hélène  Baubichon-Cortay</span>, and <span class="hlFld-ContribAuthor ">Attilio  Di Pietro</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (11)
                                     , 5753-5774. <a href="https://doi.org/10.1021/cr4006236" title="DOI URL">https://doi.org/10.1021/cr4006236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr4006236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr4006236%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTargeting%252Bthe%252BAchilles%252BHeel%252Bof%252BMultidrug-Resistant%252BCancer%252Bby%252BExploiting%252Bthe%252BFitness%252BCost%252Bof%252BResistance%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DGergely%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D31102013%26date%3D23042014%26date%3D11062014%26volume%3D114%26issue%3D11%26spage%3D5753%26epage%3D5774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Hall</span>, <span class="hlFld-ContribAuthor ">Kyle R.  Brimacombe</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Varonka</span>, <span class="hlFld-ContribAuthor ">Kristen M.  Pluchino</span>, <span class="hlFld-ContribAuthor ">Julie K.  Monda</span>, <span class="hlFld-ContribAuthor ">Jiayang  Li</span>, <span class="hlFld-ContribAuthor ">Martin J.  Walsh</span>, <span class="hlFld-ContribAuthor ">Matthew B.  Boxer</span>, <span class="hlFld-ContribAuthor ">Timothy H.  Warren</span>, <span class="hlFld-ContribAuthor ">Henry M.  Fales</span>, and <span class="hlFld-ContribAuthor ">Michael M.  Gottesman</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Evaluation of Isatin-β-thiosemicarbazones with Improved Selective Activity toward Multidrug-Resistant Cells Expressing P-Glycoprotein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (16)
                                     , 5878-5889. <a href="https://doi.org/10.1021/jm2006047" title="DOI URL">https://doi.org/10.1021/jm2006047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2006047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2006047%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BEvaluation%252Bof%252BIsatin-%2525CE%2525B2-thiosemicarbazones%252Bwith%252BImproved%252BSelective%252BActivity%252Btoward%252BMultidrug-Resistant%252BCells%252BExpressing%252BP-Glycoprotein%26aulast%3DHall%26aufirst%3DMatthew%2BD.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D12052011%26date%3D01082011%26date%3D25082011%26date%3D01072011%26volume%3D54%26issue%3D16%26spage%3D5878%26epage%3D5889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyoko  Nakagawa-Goto</span>, <span class="hlFld-ContribAuthor ">Pei-Chi  Wu</span>, <span class="hlFld-ContribAuthor ">Chin-Yu  Lai</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Hao  Zhu</span>, <span class="hlFld-ContribAuthor ">Liying  Zhang</span>, <span class="hlFld-ContribAuthor ">Takashi  Kozaka</span>, <span class="hlFld-ContribAuthor ">Emika  Ohkoshi</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>, <span class="hlFld-ContribAuthor ">Kenneth F.  Bastow</span>, and <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Antitumor Agents. 284. New Desmosdumotin B Analogues with Bicyclic B-Ring as Cytotoxic and Antitubulin Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (5)
                                     , 1244-1255. <a href="https://doi.org/10.1021/jm1011947" title="DOI URL">https://doi.org/10.1021/jm1011947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1011947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1011947%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntitumor%252BAgents.%252B284.%252BNew%252BDesmosdumotin%252BB%252BAnalogues%252Bwith%252BBicyclic%252BB-Ring%252Bas%252BCytotoxic%252Band%252BAntitubulin%252BAgents%26aulast%3DNakagawa-Goto%26aufirst%3DKyoko%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D13092010%26date%3D01022011%26date%3D10032011%26volume%3D54%26issue%3D5%26spage%3D1244%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Natural Product-Derived Chemotherapeutic Agents Based on a Medicinal Chemistry Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2010,</strong> <em>73 </em>
                                    (3)
                                     , 500-516. <a href="https://doi.org/10.1021/np900821e" title="DOI URL">https://doi.org/10.1021/np900821e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/np900821e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnp900821e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BNatural%252BProduct-Derived%252BChemotherapeutic%252BAgents%252BBased%252Bon%252Ba%252BMedicinal%252BChemistry%252BApproach%26aulast%3DLee%26aufirst%3DKuo-Hsiung%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D16%252012%25202009%26date%3D26022010%26date%3D26032010%26volume%3D73%26issue%3D3%26spage%3D500%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohei  Saito</span>, <span class="hlFld-ContribAuthor ">Yukako  Taniguchi</span>, <span class="hlFld-ContribAuthor ">Sachika  Hirazawa</span>, <span class="hlFld-ContribAuthor ">Yuta  Miura</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Tsurimoto</span>, <span class="hlFld-ContribAuthor ">Tomoki  Nakayoshi</span>, <span class="hlFld-ContribAuthor ">Akifumi  Oda</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Katsumi  Yamashita</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>, <span class="hlFld-ContribAuthor ">Kyoko  Nakagawa-Goto</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of substituent pattern on the intracellular target of antiproliferative benzo[b]thiophenyl chromone derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113578. <a href="https://doi.org/10.1016/j.ejmech.2021.113578" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113578%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffects%252Bof%252Bsubstituent%252Bpattern%252Bon%252Bthe%252Bintracellular%252Btarget%252Bof%252Bantiproliferative%252Bbenzo%25255Bb%25255Dthiophenyl%252Bchromone%252Bderivatives%26aulast%3DSaito%26aufirst%3DYohei%26date%3D2021%26volume%3D222%26spage%3D113578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Tzu  Chang</span>, <span class="hlFld-ContribAuthor ">Yu-Ning  Teng</span>, <span class="hlFld-ContribAuthor ">Kun-I  Lin</span>, <span class="hlFld-ContribAuthor ">Charles C. N.  Wang</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Chin-Chuan  Hung</span>. </span><span class="cited-content_cbyCitation_article-title">Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-48169-2" title="DOI URL">https://doi.org/10.1038/s41598-019-48169-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-48169-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-48169-2%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDanazol%252Bmediates%252Bcollateral%252Bsensitivity%252Bvia%252BSTAT3%25252FMyc%252Brelated%252Bpathway%252Bin%252Bmultidrug-resistant%252Bcancer%252Bcells%26aulast%3DChang%26aufirst%3DYing-Tzu%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin-Yu  Wen</span>, <span class="hlFld-ContribAuthor ">Hai  Liang</span>, <span class="hlFld-ContribAuthor ">Hong-Ju  Guo</span>, <span class="hlFld-ContribAuthor ">Jiu-Hong  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and antitumor activity of desmosdumotin C analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Asian Natural Products Research</span><span> <strong>2019,</strong> <em>21 </em>
                                    (7)
                                     , 702-715. <a href="https://doi.org/10.1080/10286020.2018.1473383" title="DOI URL">https://doi.org/10.1080/10286020.2018.1473383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10286020.2018.1473383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10286020.2018.1473383%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Asian%2520Natural%2520Products%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bantitumor%252Bactivity%252Bof%252Bdesmosdumotin%252BC%252Banalogues%26aulast%3DWen%26aufirst%3DBin-Yu%26date%3D2019%26date%3D2018%26volume%3D21%26issue%3D7%26spage%3D702%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatima  Naaz</span>, <span class="hlFld-ContribAuthor ">Md Rafi  Haider</span>, <span class="hlFld-ContribAuthor ">Syed  Shafi</span>, <span class="hlFld-ContribAuthor ">M. Shahar  Yar</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 310-331. <a href="https://doi.org/10.1016/j.ejmech.2019.03.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnti-tubulin%252Bagents%252Bof%252Bnatural%252Borigin%25253A%252BTargeting%252Btaxol%25252C%252Bvinca%25252C%252Band%252Bcolchicine%252Bbinding%252Bdomains%26aulast%3DNaaz%26aufirst%3DFatima%26date%3D2019%26volume%3D171%26spage%3D310%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yukiko  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Yohei  Saito</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>, <span class="hlFld-ContribAuthor ">Kyoko  Nakagawa-Goto</span>. </span><span class="cited-content_cbyCitation_article-title">Antitubulin effects of aminobenzothiophene-substituted triethylated chromones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (12)
                                     , 2731-2735. <a href="https://doi.org/10.1016/j.bmcl.2017.04.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAntitubulin%252Beffects%252Bof%252Baminobenzothiophene-substituted%252Btriethylated%252Bchromones%26aulast%3DKobayashi%26aufirst%3DYukiko%26date%3D2017%26volume%3D27%26issue%3D12%26spage%3D2731%26epage%3D2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">András  Füredi</span>, <span class="hlFld-ContribAuthor ">Szilárd  Tóth</span>, <span class="hlFld-ContribAuthor ">Kornélia  Szebényi</span>, <span class="hlFld-ContribAuthor ">Veronika F.S.  Pape</span>, <span class="hlFld-ContribAuthor ">Dóra  Türk</span>, <span class="hlFld-ContribAuthor ">Nóra  Kucsma</span>, <span class="hlFld-ContribAuthor ">László  Cervenak</span>, <span class="hlFld-ContribAuthor ">József  Tóvári</span>, <span class="hlFld-ContribAuthor ">Gergely  Szakács</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (1)
                                     , 45-56. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0333-T" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0333-T</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0333-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0333-T%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DIdentification%252Band%252BValidation%252Bof%252BCompounds%252BSelectively%252BKilling%252BResistant%252BCancer%25253A%252BDelineating%252BCell%252BLine%2525E2%252580%252593Specific%252BEffects%252Bfrom%252BP-Glycoprotein%2525E2%252580%252593Induced%252BToxicity%26aulast%3DF%25C3%25BCredi%26aufirst%3DAndr%25C3%25A1s%26date%3D2017%26date%3D2016%26volume%3D16%26issue%3D1%26spage%3D45%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyoko  Nakagawa-Goto</span>, <span class="hlFld-ContribAuthor ">Yukako  Taniguchi</span>, <span class="hlFld-ContribAuthor ">Yurie  Watanabe</span>, <span class="hlFld-ContribAuthor ">Akifumi  Oda</span>, <span class="hlFld-ContribAuthor ">Emika  Ohkoshi</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>. </span><span class="cited-content_cbyCitation_article-title">Triethylated chromones with substituted naphthalenes as tubulin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (22)
                                     , 6048-6057. <a href="https://doi.org/10.1016/j.bmc.2016.09.062" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.09.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.09.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.09.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTriethylated%252Bchromones%252Bwith%252Bsubstituted%252Bnaphthalenes%252Bas%252Btubulin%252Binhibitors%26aulast%3DNakagawa-Goto%26aufirst%3DKyoko%26date%3D2016%26volume%3D24%26issue%3D22%26spage%3D6048%26epage%3D6057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. N. Visweswara  Sastry</span>, <span class="hlFld-ContribAuthor ">Sunitha Rani  Routhu</span>, <span class="hlFld-ContribAuthor ">Soma Gupta  Datta</span>, <span class="hlFld-ContribAuthor ">Narayana  Nagesh</span>, <span class="hlFld-ContribAuthor ">Bathini Nagendra  Babu</span>, <span class="hlFld-ContribAuthor ">Jagadeesh Babu  Nanubolu</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Ram Awatar  Maurya</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (39)
                                     , 9294-9305. <a href="https://doi.org/10.1039/C6OB01077F" title="DOI URL">https://doi.org/10.1039/C6OB01077F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01077F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01077F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%25252C%252BDNA%252Bbinding%252Baffinity%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252B4H-benzo%25255Bg%25255D%25255B1%25252C2%25252C3%25255Dtriazolo%25255B5%25252C1-c%25255D%25255B1%25252C4%25255Doxazocines%26aulast%3DSastry%26aufirst%3DK.%2BN.%2BVisweswara%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D39%26spage%3D9294%26epage%3D9305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinmiao  Lu</span>, <span class="hlFld-ContribAuthor ">Cheng  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhangchi  Ning</span>, <span class="hlFld-ContribAuthor ">Honglian  Zeng</span>, <span class="hlFld-ContribAuthor ">Xinzhe  Ding</span>, <span class="hlFld-ContribAuthor ">Yinhuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng  Lu</span>, <span class="hlFld-ContribAuthor ">Yuanyan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Diversified bioactivities of four types of naturally occurring quinochalcones. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2014,</strong> <em>99 </em>, 7-20. <a href="https://doi.org/10.1016/j.fitote.2014.08.017" title="DOI URL">https://doi.org/10.1016/j.fitote.2014.08.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2014.08.017%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DDiversified%252Bbioactivities%252Bof%252Bfour%252Btypes%252Bof%252Bnaturally%252Boccurring%252Bquinochalcones%26aulast%3DZhao%26aufirst%3DSiyu%26date%3D2014%26volume%3D99%26spage%3D7%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Callaghan</span>, <span class="hlFld-ContribAuthor ">Frederick  Luk</span>, <span class="hlFld-ContribAuthor ">Mary  Bebawy</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2014,</strong> <em>42 </em>
                                    (4)
                                     , 623-631. <a href="https://doi.org/10.1124/dmd.113.056176" title="DOI URL">https://doi.org/10.1124/dmd.113.056176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.113.056176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.113.056176%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DInhibition%252Bof%252Bthe%252BMultidrug%252BResistance%252BP-Glycoprotein%25253A%252BTime%252Bfor%252Ba%252BChange%252Bof%252BStrategy%25253F%26aulast%3DCallaghan%26aufirst%3DRichard%26date%3D2014%26date%3D2014%26volume%3D42%26issue%3D4%26spage%3D623%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khyati  Kapoor</span>, <span class="hlFld-ContribAuthor ">Hong May  Sim</span>, <span class="hlFld-ContribAuthor ">Suresh V.  Ambudkar</span>. </span><span class="cited-content_cbyCitation_article-title">Multidrug Resistance in Cancer: A Tale of ABC Drug Transporters. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 1-34. <a href="https://doi.org/10.1007/978-1-4614-7070-0_1" title="DOI URL">https://doi.org/10.1007/978-1-4614-7070-0_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-7070-0_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-7070-0_1%26sid%3Dliteratum%253Aachs%26atitle%3DMultidrug%252BResistance%252Bin%252BCancer%25253A%252BA%252BTale%252Bof%252BABC%252BDrug%252BTransporters%26aulast%3DKapoor%26aufirst%3DKhyati%26date%3D2013%26date%3D2013%26spage%3D1%26epage%3D34%26pub%3DSpringer%2520New%2520York%26atitle%3DMolecular%252BMechanisms%252Bof%252BTumor%252BCell%252BResistance%252Bto%252BChemotherapy%26aulast%3DBonavida%26aufirst%3DBenjamin%26date%3D2013%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Saeed</span>, <span class="hlFld-ContribAuthor ">Henry Johannes  Greten</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>. </span><span class="cited-content_cbyCitation_article-title">Collateral Sensitivity in Drug-Resistant Tumor Cells. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 187-211. <a href="https://doi.org/10.1007/978-1-4614-7070-0_10" title="DOI URL">https://doi.org/10.1007/978-1-4614-7070-0_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-7070-0_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-7070-0_10%26sid%3Dliteratum%253Aachs%26atitle%3DCollateral%252BSensitivity%252Bin%252BDrug-Resistant%252BTumor%252BCells%26aulast%3DSaeed%26aufirst%3DMohamed%26date%3D2013%26date%3D2013%26spage%3D187%26epage%3D211%26pub%3DSpringer%2520New%2520York%26atitle%3DMolecular%252BMechanisms%252Bof%252BTumor%252BCell%252BResistance%252Bto%252BChemotherapy%26aulast%3DBonavida%26aufirst%3DBenjamin%26date%3D2013%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Lu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Xiao</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Duane D.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2012,</strong> <em>29 </em>
                                    (11)
                                     , 2943-2971. <a href="https://doi.org/10.1007/s11095-012-0828-z" title="DOI URL">https://doi.org/10.1007/s11095-012-0828-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DAn%252BOverview%252Bof%252BTubulin%252BInhibitors%252BThat%252BInteract%252Bwith%252Bthe%252BColchicine%252BBinding%252BSite%26aulast%3DLu%26aufirst%3DYan%26date%3D2012%26date%3D2012%26volume%3D29%26issue%3D11%26spage%3D2943%26epage%3D2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristen M.  Pluchino</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hall</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Goldsborough</span>, <span class="hlFld-ContribAuthor ">Richard  Callaghan</span>, <span class="hlFld-ContribAuthor ">Michael M.  Gottesman</span>. </span><span class="cited-content_cbyCitation_article-title">Collateral sensitivity as a strategy against cancer multidrug resistance. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2012,</strong> <em>15 </em>
                                    (1-2)
                                     , 98-105. <a href="https://doi.org/10.1016/j.drup.2012.03.002" title="DOI URL">https://doi.org/10.1016/j.drup.2012.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2012.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DCollateral%252Bsensitivity%252Bas%252Ba%252Bstrategy%252Bagainst%252Bcancer%252Bmultidrug%252Bresistance%26aulast%3DPluchino%26aufirst%3DKristen%2BM.%26date%3D2012%26volume%3D15%26issue%3D1-2%26spage%3D98%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Ou</span>, <span class="hlFld-ContribAuthor ">Shuang  Han</span>, <span class="hlFld-ContribAuthor ">Wenbo  Ding</span>, <span class="hlFld-ContribAuthor ">Zhe  Chen</span>, <span class="hlFld-ContribAuthor ">Ziqi  Ye</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Goulin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yijia  Lou</span>, <span class="hlFld-ContribAuthor ">Jian-Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Yongping  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and 3D-QSAR study of cytotoxic flavonoid derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2011,</strong> <em>15 </em>
                                    (3)
                                     , 665-675. <a href="https://doi.org/10.1007/s11030-010-9289-7" title="DOI URL">https://doi.org/10.1007/s11030-010-9289-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-010-9289-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-010-9289-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252B3D-QSAR%252Bstudy%252Bof%252Bcytotoxic%252Bflavonoid%252Bderivatives%26aulast%3DOu%26aufirst%3DLili%26date%3D2011%26date%3D2010%26volume%3D15%26issue%3D3%26spage%3D665%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting-Chun  Kuo</span>, <span class="hlFld-ContribAuthor ">Po-Cheng  Chiang</span>, <span class="hlFld-ContribAuthor ">Chia-Chun  Yu</span>, <span class="hlFld-ContribAuthor ">Kyoko  Nakagawa-Goto</span>, <span class="hlFld-ContribAuthor ">Kenneth F.  Bastow</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Jih-Hwa  Guh</span>. </span><span class="cited-content_cbyCitation_article-title">A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2011,</strong> <em>81 </em>
                                    (9)
                                     , 1136-1144. <a href="https://doi.org/10.1016/j.bcp.2011.02.013" title="DOI URL">https://doi.org/10.1016/j.bcp.2011.02.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2011.02.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DA%252Bunique%252BP-glycoprotein%252Binteracting%252Bagent%252Bdisplays%252Banticancer%252Bactivity%252Bagainst%252Bhepatocellular%252Bcarcinoma%252Bthrough%252Binhibition%252Bof%252BGRP78%252Band%252BmTOR%252Bpathways%26aulast%3DKuo%26aufirst%3DTing-Chun%26date%3D2011%26volume%3D81%26issue%3D9%26spage%3D1136%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Hall</span>, <span class="hlFld-ContribAuthor ">Misty D.  Handley</span>, <span class="hlFld-ContribAuthor ">Michael M.  Gottesman</span>. </span><span class="cited-content_cbyCitation_article-title">Is resistance useless? Multidrug resistance and collateral sensitivity. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2009,</strong> <em>30 </em>
                                    (10)
                                     , 546-556. <a href="https://doi.org/10.1016/j.tips.2009.07.003" title="DOI URL">https://doi.org/10.1016/j.tips.2009.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2009.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2009.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DIs%252Bresistance%252Buseless%25253F%252BMultidrug%252Bresistance%252Band%252Bcollateral%252Bsensitivity%26aulast%3DHall%26aufirst%3DMatthew%2BD.%26date%3D2009%26volume%3D30%26issue%3D10%26spage%3D546%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ngoc Tuan  Nguyen</span>, <span class="hlFld-ContribAuthor ">Van Cuong  Pham</span>, <span class="hlFld-ContribAuthor ">Marc  Litaudon</span>, <span class="hlFld-ContribAuthor ">Françoise  Guéritte</span>, <span class="hlFld-ContribAuthor ">Bernard  Bodo</span>, <span class="hlFld-ContribAuthor ">Van Tuyen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Van Hung  Nguyen</span>. </span><span class="cited-content_cbyCitation_article-title">Novel cyclopeptide and unique flavone from Desmos rostrata. Total synthesis of desmorostratone. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2009,</strong> <em>65 </em>
                                    (34)
                                     , 7171-7176. <a href="https://doi.org/10.1016/j.tet.2009.06.017" title="DOI URL">https://doi.org/10.1016/j.tet.2009.06.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2009.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2009.06.017%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DNovel%252Bcyclopeptide%252Band%252Bunique%252Bflavone%252Bfrom%252BDesmos%252Brostrata.%252BTotal%252Bsynthesis%252Bof%252Bdesmorostratone%26aulast%3DNguyen%26aufirst%3DNgoc%2BTuan%26date%3D2009%26volume%3D65%26issue%3D34%26spage%3D7171%26epage%3D7176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0003.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of <b>1</b>-Analogues</div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (i) RI (3 mol equiv), NaOMe (3 mol equiv), MeOH, reflux. (R = Me for <b>35a</b>, R = Et for <b>35d</b>, R = Pr for <b>35e</b>). (ii) (1) BF<sub>3</sub>·OEt<sub>2</sub>, HOAc/Ac<sub>2</sub>O, (2) MeI, NaOMe, MeOH, reflux, (3) 85% H<sub>2</sub>SO<sub>4</sub>, heat, (4) EtI (2 mol equiv), NaOMe (1 mol equiv), MeOH, reflux. (iii) TMSCHN<sub>2</sub>, −78 to −40°C. (iv) ArCHO, 50% KOH, EtOH, rt, 1−3 days. (v) I<sub>2</sub>, DMSO, conc H<sub>2</sub>SO<sub>4</sub>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. (vi) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt. (vii) (1) PhCHO, 50% KOH, EtOH, microwave, 90 °C, 20 min; (2) I<sub>2</sub>, DMSO, microwave, 190 °C, 5 min.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0004.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of isoflavone <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) EtI (3 mol equiv), NaOMe (3 mol equiv), MeOH, reflux, 50%. (ii) BF<sub>3</sub>·OEt<sub>2</sub>, PCl<sub>5</sub>, DMF, 68%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/medium/jm-2007-01208v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reversal effects of <b>1</b> and <b>10</b> in KB-VIN cells by verapamil cotreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm701208v/production/images/large/jm-2007-01208v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701208v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span> </span><span class="NLM_article-title">Strategies for reversing drug resistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7512-7523&author=T.+Fojoauthor=S.+Bates&title=Strategies+for+reversing+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%26atitle%3DStrategies%2520for%2520reversing%2520drug%2520resistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7512%26epage%3D7523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span> </span><span class="NLM_article-title">Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1111%2Fj.1349-7006.2003.tb01345.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=12708468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2003&pages=15-21&author=T.+Tsuruoauthor=M.+Naitoauthor=A.+Tomidaauthor=N.+Fujitaauthor=T.+Mashimaauthor=H.+Sakamoto&title=Molecular+targeting+therapy+of+cancer%3A+drug+resistance%2C+apoptosis+and+survival+signal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal</span></div><div class="casAuthors">Tsuruo, Takashi; Naito, Mikihiko; Tomida, Akihiro; Fujita, Naoya; Mashima, Tetsuo; Sakamoto, Hiroshi; Haga, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">A review.  Recent progress in the development of mol. cancer therapeutics has revealed new types of antitumor drugs, such as Herceptin, Gleevec, and Iressa, as potent therapeutics for specific tumors.  Our work has focused on mol. cancer therapeutics, mainly in the areas of drug resistance, apoptosis and apoptosis resistance, and survival-signaling, which is related to drug resistance.  In this review, we describe our research on mol. cancer therapeutics, including mol. mechanisms and therapeutic approaches.  Resistance to chemotherapeutic drugs is a principal problem in the treatment of cancer.  P-Glycoprotein (P-gp), encoded by the MDR1 gene, is a multidrug transporter and has a major role in multidrug resistance (MDR).  Targeting of P-gp by small-mol. compds. and/or antibodies is an effective strategy to overcome MDR in cancer, esp. hematol. malignancies.  Several P-gp inhibitors have been developed and are currently under clin. phased studies.  In addn. to the multi-drug transporter proteins, cancer cells have several drug resistance mechanisms.  Solid tumors are often placed under stress conditions, such as glucose starvation and hypoxia.  These conditions result in topo II poison resistance that is due to proteasome-mediated degrdn. of DNA topoisomerases.  Proteasome inhibitors effectively prevent this stress-induced drug resistance.  Glyoxalase I, which is often elevated in drug- and apoptosis-resistant cancers, offers another possibility for overcoming drug resistance.  It plays a role in detoxification of methylglioxal, a side product of glycolysis, which is highly reactive with DNA and proteins.  Inhibitors of glyoxalase I selectively kill drug-resistant tumors that express glyoxalase I.  Finally, the susceptibility of tumor cells to apoptosis induced by antitumor drugs appears to depend on the balance between pro-apoptotic and survival (anti-apoptotic) signals.  PI3K-Akt is an important survival signal pathway, that has been shown to be the target of various antitumor drugs, including UCN-01 and geldanamycin, new anticancer drugs under clin. evaluation.  Our present studies provide novel targets for future effective mol. cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVV4UtvIrFULVg90H21EOLACvtfcHk0lidn4jHJCkUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFektLY%253D&md5=c7c87d1ccace5c57183ece07013dfe16</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2003.tb01345.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2003.tb01345.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DM.%26aulast%3DTomida%26aufirst%3DA.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DMashima%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26atitle%3DMolecular%2520targeting%2520therapy%2520of%2520cancer%253A%2520drug%2520resistance%252C%2520apoptosis%2520and%2520survival%2520signal%26jtitle%3DCancer%2520Sci.%26date%3D2003%26volume%3D94%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ambudkar, S. V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimchi-Sarfaty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauna, Z. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">P-glycoprotein: from genomics to mechanism</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7468</span><span class="NLM_x">–</span> <span class="NLM_lpage">7485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=7468-7485&author=S.+V+Ambudkarauthor=C.+Kimchi-Sarfatyauthor=Z.+E.+Saunaauthor=M.+M.+Gottesman&title=P-glycoprotein%3A+from+genomics+to+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbudkar%26aufirst%3DS.%2BV%26aulast%3DKimchi-Sarfaty%26aufirst%3DC.%26aulast%3DSauna%26aufirst%3DZ.%2BE.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DP-glycoprotein%253A%2520from%2520genomics%2520to%2520mechanism%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D7468%26epage%3D7485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Leonard, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S.</span><span> </span><span class="NLM_article-title">The role of ABC transporters in clinical practice</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1634%2Ftheoncologist.8-5-411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=14530494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=411-424&author=G.+D.+Leonardauthor=T.+Fojoauthor=S.+Bates&title=The+role+of+ABC+transporters+in+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ABC transporters in clinical practice</span></div><div class="casAuthors">Leonard, Gregory D.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-424</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  Drug resistance remains one of the primary causes of suboptimal outcomes in cancer therapy.  ATP-binding cassette (ABC) transporters are a family of transporter proteins that contribute to drug resistance via ATP-dependent drug efflux pumps.  P-glycoprotein (P-gp), encoded by the MDR1 gene, is an ABC transporter normally involved in the excretion of toxins from cells.  It also confers resistance to certain chemotherapeutic agents.  P-gp is overexpressed at baseline in chemotherapy-resistant tumors, such as colon and kidney cancers, and is upregulated after disease progression following chemotherapy in malignancies such as leukemia and breast cancer.  Other transporter proteins mediating drug resistance include those in the multidrug-resistance-assocd. protein (MRP) family, notably MRP1, and ABCG2.  These transporters are also involved in normal physiol. functions.  The expressions of MRP family members and ABCG2 were not well worked out in cancer.  Increased drug accumulation and drug resistance reversal with P-gp inhibitors were well documented in vitro, but only suggested in clin. trials.  Limitations in the design of early resistance reversal trials contributed to disappointing results.  Despite this, 3 randomized trials have shown statistically significant benefits with the use of a P-gp inhibitor in combination with chemotherapy.  Improved diagnostic techniques aimed at the selection of patients with tumors that express P-gp should result in more successful outcomes.  Further optimism is warranted with the advent of potent, nontoxic inhibitors and new treatment strategies, including the combination of new targeted therapies with therapies aimed at the prevention of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr317MZ9jawCbVg90H21EOLACvtfcHk0lh_gpBwAEyYsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslyls74%253D&md5=b474f45fd5c45962acfff61840c04a6b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.8-5-411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.8-5-411%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DG.%2BD.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520ABC%2520transporters%2520in%2520clinical%2520practice%26jtitle%3DOncologist%26date%3D2003%26volume%3D8%26spage%3D411%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer, role of ATP-dependent transporter</span> <span class="citation_source-journal">Nat. Rev. Can.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%2C+role+of+ATP-dependent+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lh_gpBwAEyYsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%252C%2520role%2520of%2520ATP-dependent%2520transporter%26jtitle%3DNat.%2520Rev.%2520Can.%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Litman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druley, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">From MDR to MXR: new understanding of multidrug resistance system, their properties in clinical significance</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1007%2FPL00000912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11497241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=931-959&author=T.+Litmanauthor=T.+E.+Druleyauthor=W.+D.+Steinauthor=S.+E.+Bates&title=From+MDR+to+MXR%3A+new+understanding+of+multidrug+resistance+system%2C+their+properties+in+clinical+significance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance</span></div><div class="casAuthors">Litman, T.; Druley, T. E.; Stein, W. D.; Bates, S. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">931-959</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review, with 235 refs.  The ATP binding cassette (ABC) superfamily of membrane transporters is one of the largest protein classes known, and counts numerous proteins involved in the trafficking of biol. mols. across cell membranes.  The first known human ABC transporter was P-glycoprotein (P-gp), which confers multidrug resistance (MDR) to anticancer drugs.  In recent years, we have obtained an increased understanding of the mechanism of action of P-gp as its ATPase activity, substrate specificity and pharmacokinetic interactions have been investigated.  This review focuses on the functional characterization of P-gp, as well as other ABC transporters involved in MDR: the family of multidrug-resistance-assocd. proteins (MRP1-7), and the recently discovered ABC half-transporter MXR (also known as BCRP, ABCP and ABCG2).  We describe recent progress in the anal. of protein structure-function relationships, and consider the conceptual problem of defining and identifying substrates and inhibitors of MDR.  An in-depth discussion follows of how coupling of nucleotide hydrolysis to substrate transport takes place, and we propose a scheme for the mechanism of P-gp function.  Finally, the clin. correlations, both for reversal of MDR in cancer and for drug delivery, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWgL9Rzpb_qLVg90H21EOLACvtfcHk0lh_gpBwAEyYsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSms74%253D&md5=0beeb6d215da60fbdec088848fde9831</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2FPL00000912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00000912%26sid%3Dliteratum%253Aachs%26aulast%3DLitman%26aufirst%3DT.%26aulast%3DDruley%26aufirst%3DT.%2BE.%26aulast%3DStein%26aufirst%3DW.%2BD.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DFrom%2520MDR%2520to%2520MXR%253A%2520new%2520understanding%2520of%2520multidrug%2520resistance%2520system%252C%2520their%2520properties%2520in%2520clinical%2520significance%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2001%26volume%3D58%26spage%3D931%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sawicka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skierski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewandowski, W.</span><span> </span><span class="NLM_article-title">A review of selected antitumor therapeutic agents and reasons for multidrug resistance occurrence</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1211%2F0022357044265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=15324475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlGltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=1067-1087&author=M.+Sawickaauthor=M.+Kalinowskaauthor=J.+Skierskiauthor=W.+Lewandowski&title=A+review+of+selected+antitumor+therapeutic+agents+and+reasons+for+multidrug+resistance+occurrence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence</span></div><div class="casAuthors">Sawicka, M.; Kalinowska, M.; Skierski, J.; Lewandowski, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1067-1081</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review with refs.  It is assumed that proteins from the ABC family (i.e., glycoprotein P (Pgp)) and a multidrug resistance assocd. protein (MRP) play a main role in the occurrence of multidrug resistance (MDR) in tumor cells.  Other factors that influence the rise of MDR are mechanisms connected with change in the effectiveness of the glutathione cycle and with decrease in expression of topoisomerases I and II.  The aim of this review is to characterize drugs applied in anti-tumor therapy and to describe the present state of knowledge concerning the mechanisms of MDR occurrence, as well as the pharmacol. agents applied in reducing this phenomenon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNa5Qj6Igj57Vg90H21EOLACvtfcHk0libmLDk2ewzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlGltLg%253D&md5=b5e0244957983ed0a30fd3984d1d7ad6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1211%2F0022357044265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357044265%26sid%3Dliteratum%253Aachs%26aulast%3DSawicka%26aufirst%3DM.%26aulast%3DKalinowska%26aufirst%3DM.%26aulast%3DSkierski%26aufirst%3DJ.%26aulast%3DLewandowski%26aufirst%3DW.%26atitle%3DA%2520review%2520of%2520selected%2520antitumor%2520therapeutic%2520agents%2520and%2520reasons%2520for%2520multidrug%2520resistance%2520occurrence%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2004%26volume%3D56%26spage%3D1067%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, V.</span><span> </span><span class="NLM_article-title">The biochemistry of P-glycoprotein-mediated multidrug resistance</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1146%2Fannurev.bi.58.070189.001033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=2570548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADyaL1MXkslSiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1989&pages=137-171&author=J.+A.+Endicottauthor=V.+Ling&title=The+biochemistry+of+P-glycoprotein-mediated+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemistry of P-glycoprotein-mediated multidrug resistance</span></div><div class="casAuthors">Endicott, Jane A.; Ling, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">137-71</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    </div><div class="casAbstract">A review with 192 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTZVaPn5Fj27Vg90H21EOLACvtfcHk0libmLDk2ewzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkslSiu7w%253D&md5=9b848bff38fec4a7b9d2463602f7805c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.58.070189.001033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.58.070189.001033%26sid%3Dliteratum%253Aachs%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DLing%26aufirst%3DV.%26atitle%3DThe%2520biochemistry%2520of%2520P-glycoprotein-mediated%2520multidrug%2520resistance%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1989%26volume%3D58%26spage%3D137%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cole, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, E. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span> </span><span class="NLM_article-title">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+P.+Coleauthor=G.+Bhardwajauthor=J.+H.+Gerlachauthor=J.+E.+Mackieauthor=C.+E.+Grantauthor=K.+C.+Almquistauthor=A.+J+Stewartauthor=E.+U.+Kurzauthor=A.+M.+Duncanauthor=R.+G.+Deeley&title=Overexpression+of+a+transporter+gene+in+a+multidrug-resistant+human+lung+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0libmLDk2ewzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DMackie%26aufirst%3DJ.%2BE.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BJ%26aulast%3DKurz%26aufirst%3DE.%2BU.%26aulast%3DDuncan%26aufirst%3DA.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DOverexpression%2520of%2520a%2520transporter%2520gene%2520in%2520a%2520multidrug-resistant%2520human%2520lung%2520cancer%2520cell%2520line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Borst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnholds, J.</span><span> </span><span class="NLM_article-title">A family of drug transporters: the multidrug resistance-associated proteins</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1093%2Fjnci%2F92.16.1295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=10944550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlektr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1295-1302&author=P.+Borstauthor=R.+Eversauthor=M.+Koolauthor=J.+Wijnholds&title=A+family+of+drug+transporters%3A+the+multidrug+resistance-associated+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A family of drug transporters: The multidrug resistance-associated proteins</span></div><div class="casAuthors">Borst, Piet; Evers, Raymond; Kool, Marcel; Wijnholds, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1295-1302</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 93 refs.  The human multidrug resistance-assocd. protein (MRP) family currently has seven members.  The ability of several of these membrane proteins to transport a wide range of anti-cancer drugs out of cells and their presence in many tumors make them prime suspects in unexplained cases of drug resistance, although proof that they contribute to clin. drug resistance is still lacking.  Recent studies have begun to clarify the function of the MRP family members.  MRPs are org. anion transporters; i.e., they transport anionic drugs, exemplified by methotrexate, and neutral drugs conjugated to acidic ligands, such as glutathione (GSH), glucuronate, or sulfate.  However, MRP1, MRP2, and MRP3 can also cause resistance to neutral org. drugs that are not known to be conjugated to acidic ligands by transporting these drugs together with free GSH.  MRP1 can even confer resistance to arsenite and MRP2 to cisplatin, again probably by transporting these compds. in complexes with GSH.  MRP4 overexpression is assocd. with high-level resistance to the nucleoside analogs 9-(2-phosphonylmethoxyethyl) adenine and azidothymidine, both of which are used as anti-human immunodeficiency virus drugs.  MRPs may, therefore, also have a role in resistance against nucleoside analogs used in cancer chemotherapy.  Mice without Mrp1, a high-affinity leukotriene C4 transporter, have an altered response to inflammatory stimuli but are otherwise healthy and fertile.  MRP2 is the major transporter responsible for the secretion of bilirubin glucuronides into bile, and humans without MRP2 develop a mild liver disease known as the Dubin-Johnson syndrome.  The physiol. functions of the other MRPs are not known.  Whether long-term inhibition of MRPs in humans can be tolerated (assuming that suitable inhibitors will be found) remains to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoI-EICNsS7Vg90H21EOLACvtfcHk0li3jtVzVkm6Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlektr8%253D&md5=d7b5b6c8f74b1805e61ebfdbf223ad05</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.16.1295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.16.1295%26sid%3Dliteratum%253Aachs%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DKool%26aufirst%3DM.%26aulast%3DWijnholds%26aufirst%3DJ.%26atitle%3DA%2520family%2520of%2520drug%2520transporters%253A%2520the%2520multidrug%2520resistance-associated%2520proteins%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D1295%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Leslie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. P.</span><span> </span><span class="NLM_article-title">Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1016%2FS0300-483X%2801%2900454-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11557126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXms12nurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2001&pages=3-23&author=E.+M.+Leslieauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Toxicological+relevance+of+the+multidrug+resistance+protein+1%2C+MRP1+%28ABCC1%29+and+related+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters</span></div><div class="casAuthors">Leslie, E. M.; Deeley, R. G.; Cole, S. P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-23</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The 190 kDa multidrug resistance protein 1 (MRP1/ABCC1) is a founding member of a subfamily of the ATP binding cassette (ABC) superfamily of transport proteins and was originally identified on the basis of its elevated expression in multidrug resistant lung cancer cells.  In addn. to its ability to confer resistance in tumor cells, MRP1 is ubiquitously expressed in normal tissues and is a primary active transporter of GSH, glucuronate and sulfate conjugated and unconjugated org. anions of toxicol. relevance.  Substrates include lipid peroxidn. products, herbicides, tobacco specific nitrosamines, mycotoxins, heavy metals, and natural product and antifolate anti-cancer agents.  MRP1 also transports unmodified xenobiotics but often requires GSH to do so.  Active efflux is generally an important aspect of cellular detoxification since it prevents the accumulation of conjugated and unconjugated compds. that have the potential to be directly toxic.  The related transporters MRP2 and MRP3 have overlapping substrate specificities with MRP1 but different tissue distributions, and evidence that they also have chemoprotective functions are discussed.  Finally, MRP homologs have been described in other species including yeast and nematodes.  Those isolated from the vascular plant Arabidopsis thaliana (AtMRPs) decrease the cytoplasmic concn. of conjugated toxins through sequestration in vacuoles and are implicated in providing herbicide resistance to plants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLK4gAGj-F7Vg90H21EOLACvtfcHk0li3jtVzVkm6Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXms12nurk%253D&md5=2e72d71aeecda11c673d1d63324a7449</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2801%2900454-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252801%252900454-1%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DToxicological%2520relevance%2520of%2520the%2520multidrug%2520resistance%2520protein%25201%252C%2520MRP1%2520%2528ABCC1%2529%2520and%2520related%2520transporters%26jtitle%3DToxicology%26date%3D2001%26volume%3D167%26spage%3D3%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Holland, B.; Cole, S. P. C.; Kuchler, K.; Higgins, C. F.</span>, Eds.  <span class="citation_source-book">ABC Protein from Bacteria to Man</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=B.+Holland&author=S.+P.+C.+Cole&author=K.+Kuchler&author=C.+F.+Higgins&title=ABC+Protein+from+Bacteria+to+Man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DB.%26btitle%3DABC%2520Protein%2520from%2520Bacteria%2520to%2520Man%26pub%3DAcademic%2520Press%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Takara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, K.</span><span> </span><span class="NLM_article-title">An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.2174%2F138161206775201965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=16454744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlCrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=273-286&author=K.+Takaraauthor=T.+Sakaedaauthor=K.+Okumura&title=An+update+on+overcoming+MDR1-mediated+multidrug+resistance+in+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy</span></div><div class="casAuthors">Takara, Kohji; Sakaeda, Toshiyuki; Okumura, Katsuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-286</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The intrinsic or acquired resistance to anticancer drugs remains one of the most significant factors impeding the progress of cancer chemotherapy.  This phenomenon often involves simultaneous resistance to other anticancer drugs that differ in their chem. structure and mode of action and are not even used in chemotherapy.  This phenotype has been called multidrug resistance (MDR).  Although the cellular basis underlying MDR is not fully understood, several factors mediating therapy resistance in tumors have been proposed.  One of the mechanisms leading to chemoresistance of tumor cells is the increased activity of transporter proteins.  The best-characterized transporter protein is MDR1/P-glycoprotein, and a no. of clin. investigations have suggested that its intrinsic or acquired overexpression resulted in a poor clin. outcome of chemotherapy.  Various types of compds. and techniques for the reversal of MDR1/P-glycoprotein-mediated MDR have been developed, and efforts have concd. on the inhibition of function and suppression of expression.  This review summarizes the current state of knowledge of MDR1/P-glycoprotein and the modulation of MDR by targeting MDR1/P-glycoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooxmakl8p8xrVg90H21EOLACvtfcHk0lgF_UT-qA0dhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlCrug%253D%253D&md5=d80dd638eb3b8504785ead7fcf24823b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138161206775201965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775201965%26sid%3Dliteratum%253Aachs%26aulast%3DTakara%26aufirst%3DK.%26aulast%3DSakaeda%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DK.%26atitle%3DAn%2520update%2520on%2520overcoming%2520MDR1-mediated%2520multidrug%2520resistance%2520in%2520cancer%2520chemotherapy%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D273%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Modok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, R.</span><span> </span><span class="NLM_article-title">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span> <span class="citation_source-journal">Curr. Opin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1016%2Fj.coph.2006.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=16690355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=350-354&author=S.+Modokauthor=H.+R.+Mellorauthor=R.+Callaghan&title=Modulation+of+multidrug+resistance+efflux+pump+activity+to+overcome+chemoresistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer</span></div><div class="casAuthors">Modok, Szabolcs; Mellor, Howard R.; Callaghan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-354</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Early publications using cultured cancer cells immediately recognized the phenomenon of resistance to anticancer agents.  However, it was not until 1973 that it was first demonstrated that a major factor in the resistance of cancer cells was that of reduced drug accumulation.  This year marks the 30th anniversary of the discovery by Juliano and Ling that P-glycoprotein mediates this active efflux of chemotherapeutic drugs from cancer cells.  Since this seminal finding, the investigation of P-glycoprotein (MDR1, ATP binding cassette [ABC]B1) has proceeded with great vigour.  However, it soon became apparent that P-glycoprotein was not expressed in all drug-resistant cells that displayed an accumulation deficiency, which led to the discovery of other ABC transporters involved in drug efflux.  In 1992, the multidrug resistance-assocd. protein (MRP1, ABCC1) was identified in small cell lung cancer followed by breast cancer resistance protein (mitoxantrone resistance protein, ABCG2) in 1999.  After three decades of research, can we confidently define the contribution of multidrug resistance transporters to chemoresistance and do we have clin. useful drugs to sensitize cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEJzb35-rDLVg90H21EOLACvtfcHk0lgF_UT-qA0dhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslCqu7Y%253D&md5=9fbe122b53419fa753a006af6840c326</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DModok%26aufirst%3DS.%26aulast%3DMellor%26aufirst%3DH.%2BR.%26aulast%3DCallaghan%26aufirst%3DR.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520efflux%2520pump%2520activity%2520to%2520overcome%2520chemoresistance%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharm.%26date%3D2006%26volume%3D6%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Avendaño, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menéndez, C.</span><span> </span><span class="NLM_article-title">Recent advances in multidrug resistance modulators</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlShtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=419-444&author=C.+Avenda%C3%B1oauthor=C.+Men%C3%A9ndez&title=Recent+advances+in+multidrug+resistance+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in multidrug resistance modulators</span></div><div class="casAuthors">Avendano, Carmen; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Reviews--Online</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-444</span>CODEN:
                <span class="NLM_cas:coden">MCREC9</span>;
        ISSN:<span class="NLM_cas:issn">1567-2034</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) is a type of resistance to structurally unrelated chemotherapeutic drugs, and is one of the main obstacles in the chemotherapy of cancer, malaria and other diseases.  In the case of cancer, its inhibition by combination of chemosensitizers with antitumor compds. continues to be a very active field of research, since the availability of safe and potent reversal agents would be very beneficial for clin. use.  The discovery of new structures with MDR modulating properties is taking place at a fast pace, together with the clin. evaluation of the most promising of the previously known compds.  Most modulators act by binding to membrane transport proteins (specially P-gp and MRP) and inhibiting their drug-effluxing activity, but some of them act by indirect mechanisms, including inhibition of the expression of the mdr1 gene.  General structure-activity studies of this therapeutic group are hampered by the very heterogeneous chem. structure of the compds., although some conclusions regarding the location of binding domains of P-gp and the structural requirements for MDR reversal have been drawn recently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3nOIpQnmKRbVg90H21EOLACvtfcHk0lgF_UT-qA0dhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlShtLw%253D&md5=1466401899ed12d6e27a18d2d3477617</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvenda%25C3%25B1o%26aufirst%3DC.%26aulast%3DMen%25C3%25A9ndez%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520in%2520multidrug%2520resistance%2520modulators%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2004%26volume%3D1%26spage%3D419%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lehne, G.</span><span> </span><span class="NLM_article-title">P-glycoprotein as a drug target in the treatment of multidrug resistant cancer</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.2174%2F1389450003349443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=11475537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1WhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=85-99&author=G.+Lehne&title=P-glycoprotein+as+a+drug+target+in+the+treatment+of+multidrug+resistant+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein as a drug target in the treatment of multidrug resistant cancer</span></div><div class="casAuthors">Lehne, Gustav</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-99</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 187 refs.  Multidrug resistance (MDR) is a major obstacle to successful cancer chemotherapy.  One important mechanism of MDR involves the multidrug transporter, P-glycoprotein (Pgp), which confers upon cancer cells the ability to resist LDs of certain cytotoxic drugs by pumping the drugs out of the cells and thus reducing their cytotoxicity.  Pgp belongs to the ATP-binding cassette (ABC) family of transporter mols. which require hydrolysis of ATP to run the transport mechanism.  The substrates of Pgp may be endogenous (steroid hormones, cytokines) or exogenous (cytostatic drugs).  A no. of studies have demonstrated a neg. correlation between Pgp expression levels and chemosensitivity or survival in a range of human malignancies.  In principle, Pgp mediated drug resistance can be circumvented by treatment regimens that either exclude Pgp substrate drugs or include Pgp inhibitory agents.  Exptl. studies have demonstrated that certain structural modifications of anthracyclines confer the ability to escape Pgp transport.  The therapeutic benefit of Pgp inhibitors as chemosensitizers is currently being explored in phase III clin. trials, and the first promising results have already been reported.  Another therapeutic option for Pgp inhibitors has recently evolved as several Pgp inhibitors, many of which are generally low-toxic substances, by themselves constrain proliferation and cause cell death by apoptosis in certain MDR cancer cell lines.  The dual effect of Pgp inhibitors, targeting MDR cancer cells selectively, may translate into improved efficacy of cancer chemotherapy and perhaps new and less toxic drug treatment strategies in human MDR cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMLUMMjg9OLVg90H21EOLACvtfcHk0ljsqxUloQPpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1WhtLw%253D&md5=64f838819d62e5478e19545c9104cadc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1389450003349443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450003349443%26sid%3Dliteratum%253Aachs%26aulast%3DLehne%26aufirst%3DG.%26atitle%3DP-glycoprotein%2520as%2520a%2520drug%2520target%2520in%2520the%2520treatment%2520of%2520multidrug%2520resistant%2520cancer%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2000%26volume%3D1%26spage%3D85%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baubichon-Cortay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trompier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrotton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, A.</span><span> </span><span class="NLM_article-title">Anticancer multidrug resistance mediated by MRP1: Recent advances in the discovery of reversal agents</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1002%2Fmed.20032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=15834856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntlSkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=453-472&author=A.+Boumendjelauthor=H.+Baubichon-Cortayauthor=D.+Trompierauthor=T.+Perrottonauthor=A.+Di+Pietro&title=Anticancer+multidrug+resistance+mediated+by+MRP1%3A+Recent+advances+in+the+discovery+of+reversal+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents</span></div><div class="casAuthors">Boumendjel, Abcene; Baubichon-Cortay, Helene; Trompier, Doriane; Perrotton, Thomas; Di Pietro, Attilio</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">453-472</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance protein 1 (MRP1) belongs to the ATP-binding cassette (ABC) transporter family.  It is able to transport a broad range of anticancer drugs through cellular membranes, thus limiting their antiproliferative action.  Since its discovery in 1992, MRP1 has been the most studied among MRP proteins, which now count nine members.  Besides the biol. work, which targets structure elucidation, binding sites location, and mode of action, most efforts have been focused on finding mols. which act as MRP1 inhibitors.  In this review, we attempt to summarize and highlight studies dealing with modulators of MRP1-mediated multidrug resistance (MDR), which have been accomplished in the last 5 years.  The reported MRP1 inhibitors are discussed according to their chem. class.  Finally, we try to bring information on structure-activity relationship (SAR) aspects and how modulators might interact with MRP1.  This study may facilitate the rational design of future modulators of MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr85--UhePH0rVg90H21EOLACvtfcHk0ljsqxUloQPpFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntlSkur8%253D&md5=3ee3289b71a2f12660dbd0d10b0038c2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmed.20032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20032%26sid%3Dliteratum%253Aachs%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DTrompier%26aufirst%3DD.%26aulast%3DPerrotton%26aufirst%3DT.%26aulast%3DDi%2BPietro%26aufirst%3DA.%26atitle%3DAnticancer%2520multidrug%2520resistance%2520mediated%2520by%2520MRP1%253A%2520Recent%2520advances%2520in%2520the%2520discovery%2520of%2520reversal%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D453%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mavel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palakas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emond, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greguric, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrigos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilloteau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsifis, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABBCC1/MRP1)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1599-1607&author=S.+Mavelauthor=B.+Dikicauthor=S.+Palakasauthor=P.+Emondauthor=I.+Greguricauthor=A.+G.+Graciaauthor=F.+Mattnerauthor=M.+Garrigosauthor=D.+Guilloteauauthor=A.+Katsifis&title=Synthesis+and+biological+evaluation+of+a+series+of+flavone+derivatives+as+potential+radioligands+for+imaging+the+multidrug+resistance-associated+protein+1+%28ABBCC1%2FMRP1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMavel%26aufirst%3DS.%26aulast%3DDikic%26aufirst%3DB.%26aulast%3DPalakas%26aufirst%3DS.%26aulast%3DEmond%26aufirst%3DP.%26aulast%3DGreguric%26aufirst%3DI.%26aulast%3DGracia%26aufirst%3DA.%2BG.%26aulast%3DMattner%26aufirst%3DF.%26aulast%3DGarrigos%26aufirst%3DM.%26aulast%3DGuilloteau%26aufirst%3DD.%26aulast%3DKatsifis%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520series%2520of%2520flavone%2520derivatives%2520as%2520potential%2520radioligands%2520for%2520imaging%2520the%2520multidrug%2520resistance-associated%2520protein%25201%2520%2528ABBCC1%252FMRP1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1599%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Boumendjel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietro, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barron, D.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1002%2Fmed.10015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=12210557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFSls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=512-529&author=A.+Boumendjelauthor=A.+D.+Pietroauthor=C.+Dumontetauthor=D.+Barron&title=Recent+advances+in+the+discovery+of+flavonoids+and+analogs+with+high-affinity+binding+to+P-glycoprotein+responsible+for+cancer+cell+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance</span></div><div class="casAuthors">Boumendjel, Ahcene; Di Pietro, Attilio; Dumontet, Charles; Barron, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">512-529</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  P-glycoprotein (P-gp) is a plasma membrane glycoprotein that confers multidrug resistance on cells by virtue of its ability to exclude cytotoxic drugs in an ATP-dependent manner.  The most commonly considered hypothesis is that P-gp acts as an ATP-driven drug-export pump, the mechanism of which is not understood in detail.  Therefore, a tremendous effort is being made to find out modulator mols. to inhibit P-gp.  The authors have been developing flavonoid derivs. as a new class of promising modulators using a new in vitro rational-screening assay based on measurements of the binding-affinity toward the C-terminal nucleotide-binding domain (NBD2) of P-gp.  This review is focused on the authors' results obtained with a variety of flavonoids.  Structure-activity relationships of flavonoids as potential MDR modulators are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Hsu32gRSf7Vg90H21EOLACvtfcHk0lgVGjb9uVLf-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFSls78%253D&md5=9a2f7acacf9e9997769b8331dbce10b1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fmed.10015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10015%26sid%3Dliteratum%253Aachs%26aulast%3DBoumendjel%26aufirst%3DA.%26aulast%3DPietro%26aufirst%3DA.%2BD.%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DBarron%26aufirst%3DD.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520flavonoids%2520and%2520analogs%2520with%2520high-affinity%2520binding%2520to%2520P-glycoprotein%2520responsible%2520for%2520cancer%2520cell%2520multidrug%2520resistance%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2002%26volume%3D22%26spage%3D512%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conseil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baubichon-Cortay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jault, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daskiewicz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietro, A. D.</span><span> </span><span class="NLM_article-title">Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein: Structure−activity relationships for flavonoid binding</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10382</span><span class="NLM_x">–</span> <span class="NLM_lpage">10391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10382-10391&author=H.+Wetauthor=D.+B.+McIntoshauthor=G.+Conseilauthor=H.+Baubichon-Cortayauthor=T.+Krellauthor=J.+M.+Jaultauthor=J.+B.+Daskiewiczauthor=D.+Barronauthor=A.+D.+Pietro&title=Sequence+requirements+of+the+ATP-binding+site+within+the+C-terminal+nucleotide-binding+domain+of+mouse+P-glycoprotein%3A+Structure%E2%88%92activity+relationships+for+flavonoid+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWet%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DD.%2BB.%26aulast%3DConseil%26aufirst%3DG.%26aulast%3DBaubichon-Cortay%26aufirst%3DH.%26aulast%3DKrell%26aufirst%3DT.%26aulast%3DJault%26aufirst%3DJ.%2BM.%26aulast%3DDaskiewicz%26aufirst%3DJ.%2BB.%26aulast%3DBarron%26aufirst%3DD.%26aulast%3DPietro%26aufirst%3DA.%2BD.%26atitle%3DSequence%2520requirements%2520of%2520the%2520ATP-binding%2520site%2520within%2520the%2520C-terminal%2520nucleotide-binding%2520domain%2520of%2520mouse%2520P-glycoprotein%253A%2520Structure%25E2%2588%2592activity%2520relationships%2520for%2520flavonoid%2520binding%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10382%26epage%3D10391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z. W.</span><span> </span><span class="NLM_article-title">Desmosdumotin B: A new special flavone from <i>Desmos dumosus</i></span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=49-50&author=J.-H.+Wuauthor=S.+L.+Maoauthor=S.+X.+Liaoauthor=Y.+H.+Yiauthor=C.+Q.+Lanauthor=Z.+W.+Su&title=Desmosdumotin+B%3A+A+new+special+flavone+from+Desmos+dumosus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Desmosdumotin B: a new special flavone from Desmos dumosus</span></div><div class="casAuthors">Wu, Jiu Hong; Mao, Shi Long; Liao, Shi Xuan; Yi, Yang Hua; Lan, Chuan Qing; Su, Zhong Wu</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-50</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Chinese Chemical Society</span>)
        </div><div class="casAbstract">A new special flavone, named desmosdumotin B, was isolated from the roots of D. dumosus and its chem. structure identified as 5-hydroxy-7-one-6,8,8-trimethylflavone by spectral anal. and X-ray (no data).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo091Aus2m8DrVg90H21EOLACvtfcHk0lgVGjb9uVLf-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlWktro%253D&md5=2d2ff6413a499c5c918be111fb8a7d16</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DMao%26aufirst%3DS.%2BL.%26aulast%3DLiao%26aufirst%3DS.%2BX.%26aulast%3DYi%26aufirst%3DY.%2BH.%26aulast%3DLan%26aufirst%3DC.%2BQ.%26aulast%3DSu%26aufirst%3DZ.%2BW.%26atitle%3DDesmosdumotin%2520B%253A%2520A%2520new%2520special%2520flavone%2520from%2520Desmos%2520dumosus%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D12%26spage%3D49%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wu, J.-H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Junko</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span> </span><span class="NLM_article-title">Desmosdumotin C, a novel cytotoxic principle from <i>Desmos dumosus</i></span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1391</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1391-1393&author=J.-H+Wuauthor=A.+T.+McPhailauthor=K.+F.+Bastowauthor=H.+Shirakiauthor=Junko+Itoauthor=K.-H.+Lee&title=Desmosdumotin+C%2C+a+novel+cytotoxic+principle+from+Desmos+dumosus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.-H%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DShiraki%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DJunko%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DDesmosdumotin%2520C%252C%2520a%2520novel%2520cytotoxic%2520principle%2520from%2520Desmos%2520dumosus%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D1391%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3016</span><span class="NLM_x">–</span> <span class="NLM_lpage">3019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3016-3019&author=K.+Nakagawa-Gotoauthor=K.+F.+Bastowauthor=J.-H.+Wuauthor=H.+Tokudaauthor=K.+H.+Lee&title=Total+synthesis+and+bioactivity+of+unique+flavone+desmosdumotin+B+and+its+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DTokuda%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DTotal%2520synthesis%2520and%2520bioactivity%2520of%2520unique%2520flavone%2520desmosdumotin%2520B%2520and%2520its%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3016%26epage%3D3019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span> </span><span class="NLM_article-title">First total synthesis of desmosdumotin C</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1081%2FSCC-200063907" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=1-5&author=K.+Nakagawa-Gotoauthor=J.-H+Wuauthor=K.-H.+Lee&title=First+total+synthesis+of+desmosdumotin+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1081%2FSCC-200063907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-200063907%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.-H%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DFirst%2520total%2520synthesis%2520of%2520desmosdumotin%2520C%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents 243. Syntheses and cytotoxicity of desmosdumotin C derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2325-2330&author=K.+Nakagawa-Gotoauthor=J.-H.+Wuauthor=K.+F.+Bastowauthor=C.-C.+Wuauthor=K.+H.+Lee&title=Antitumor+agents+243.+Syntheses+and+cytotoxicity+of+desmosdumotin+C+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.-H.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DWu%26aufirst%3DC.-C.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents%2520243.%2520Syntheses%2520and%2520cytotoxicity%2520of%2520desmosdumotin%2520C%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2325%26epage%3D2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Nakagawa-Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents 259. Design, syntheses and structure−activity relationship study of desmosdumotin C analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3354</span><span class="NLM_x">–</span> <span class="NLM_lpage">3358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0702534" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3354-3358&author=K.+Nakagawa-Gotoauthor=T.-H.+Chenauthor=C.-Y.+Pengauthor=K.+F.+Bastowauthor=K.+H.+Lee&title=Antitumor+agents+259.+Design%2C+syntheses+and+structure%E2%88%92activity+relationship+study+of+desmosdumotin+C+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0702534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0702534%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa-Goto%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DT.-H.%26aulast%3DPeng%26aufirst%3DC.-Y.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents%2520259.%2520Design%252C%2520syntheses%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520study%2520of%2520desmosdumotin%2520C%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3354%26epage%3D3358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, G. M.</span><span> </span><span class="NLM_article-title">An efficient “one pot” synthesis of isoflavones</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1080%2F00397910008087343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtFemu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=469-484&author=S.+Balasubramanianauthor=G.+M.+Nair&title=An+efficient+%E2%80%9Cone+pot%E2%80%9D+synthesis+of+isoflavones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient "one pot" synthesis of isoflavones</span></div><div class="casAuthors">Balasubramanian, Sreenivasan; Nair, Muraleedharan G.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-484</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Initial formation of deoxybenzoins from 4-RC6H4CH2CO2H (R = H, HO, MeO) 3,4,5-R1R2R3C6H2OH (R1 = HO, MeO, H; R2 = H, HO; R3 = H, HO) in the presence of BF3.Et2O followed by its treatment at room temp. with N,N'-dimethyl(chloromethylene)ammonium chloride, generated by reacting PCl5 with DMF provides a mild and efficient route for a "one pot" synthesis of isoflavones I in high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJU9tNGRsP_7Vg90H21EOLACvtfcHk0liddh4atIDKXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtFemu7w%253D&md5=d9ddab8d85f350e09bce5a789039c753</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00397910008087343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910008087343%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DG.%2BM.%26atitle%3DAn%2520efficient%2520%25E2%2580%259Cone%2520pot%25E2%2580%259D%2520synthesis%2520of%2520isoflavones%26jtitle%3DSynth.%2520Commun.%26date%3D2000%26volume%3D30%26spage%3D469%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><div class="note"><p class="first last">2,6-Dimethyl-DesB showed similar activity and selectivity against KB and KB-VIN to 2,4,6-trimethyl-DesB (<b>6</b>), although the data were not shown because of the low yield and difficulty of purification of this compound</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2%2C6-Dimethyl-DesB+showed+similar+activity+and+selectivity+against+KB+and+KB-VIN+to+2%2C4%2C6-trimethyl-DesB+%286%29%2C+although+the+data+were+not+shown+because+of+the+low+yield+and+difficulty+of+purification+of+this+compound."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagakura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarui, S.</span><span> </span><span class="NLM_article-title">Pharmacogenomics of drug transporters: a new approach to functional analysis of ABCB1 (P-glycoprotein/MDR1)</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1248%2Fbpb.27.939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=15256718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFKku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=939-948&author=T.+Ishikawaauthor=Y.+Onishiauthor=H.+Hiranoauthor=K.+Oosumiauthor=M.+Nagakuraauthor=S.+Tarui&title=Pharmacogenomics+of+drug+transporters%3A+a+new+approach+to+functional+analysis+of+ABCB1+%28P-glycoprotein%2FMDR1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacogenomics of drug transporters: A new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1)</span></div><div class="casAuthors">Ishikawa, Toshihisa; Onishi, Yuko; Hirano, Hiroyuki; Oosumi, Keisuke; Nagakura, Makoto; Tarui, Shigeki</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">939-948</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  In the 21st century, emerging genomic technologies (i.e., bioinformatics, functional genomics, and pharmacogenomics) are shifting the paradigm of drug discovery research and improving the strategy of medical care for patients.  In order to realize the personalized medicine, it is critically important to understand mol. mechanisms underlying inter-individual differences in the drug response, namely, pharmacol. effect vs. side effect.  Evidence is now accumulating to strongly suggest that drug transporters are one of the determinant factors governing the pharmacokinetic profile of drugs.  Effort has been made to identify genetic variation in drug transporter genes.  In particular, genetic variations of the human ABCB1 (P-glycoprotein/MDR1) gene have been most extensively studied.  Hitherto more than fifty single nucleotide polymorphisms (SNPs) and insertion/deletion polymorphisms in the ABCB1 gene have been reported.  However, at the present time, information is still limited with respect to the actual effect of those genetic polymorphisms on the function of ABCB1.  In this context, we have undertaken functional analyses of ABCB1 polymorphisms.  To quantify the impact of genetic polymorphisms on the substrate specificity of ABCB1, we have developed a high-speed screening system and a new structure-activity relationship (SAR) anal. method.  This review addresses functional aspects of the genetic polymorphism of ABCB1 and provides the std. method to evaluate the effect of polymorphisms on the function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRupwwVS1JdbVg90H21EOLACvtfcHk0liddh4atIDKXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFKku7k%253D&md5=4f1182f0dac18c7465e186d7e9196ce8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1248%2Fbpb.27.939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.27.939%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DOnishi%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DH.%26aulast%3DOosumi%26aufirst%3DK.%26aulast%3DNagakura%26aufirst%3DM.%26aulast%3DTarui%26aufirst%3DS.%26atitle%3DPharmacogenomics%2520of%2520drug%2520transporters%253A%2520a%2520new%2520approach%2520to%2520functional%2520analysis%2520of%2520ABCB1%2520%2528P-glycoprotein%252FMDR1%2529%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2004%26volume%3D27%26spage%3D939%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kimchi-Sarfaty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauna, Z. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calcagno, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">A “silent” polymorphism in the MDR1 gene changes substrate specificity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=525-528&author=C.+Kimchi-Sarfatyauthor=J.+M.+Ohauthor=I.+W.+Kimauthor=Z.+E.+Saunaauthor=A.+M.+Calcagnoauthor=S.+V.+Ambudkarauthor=M.+M.+Gottesman&title=A+%E2%80%9Csilent%E2%80%9D+polymorphism+in+the+MDR1+gene+changes+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimchi-Sarfaty%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DI.%2BW.%26aulast%3DSauna%26aufirst%3DZ.%2BE.%26aulast%3DCalcagno%26aufirst%3DA.%2BM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DA%2520%25E2%2580%259Csilent%25E2%2580%259D%2520polymorphism%2520in%2520the%2520MDR1%2520gene%2520changes%2520substrate%2520specificity%26jtitle%3DScience%26date%3D2007%26volume%3D26%26spage%3D525%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span> </span><span class="NLM_article-title">The NCI60 human tumour cell line anticancer drug screen</span> <span class="citation_source-journal">Nature Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1038%2Fnrc1951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=813-823&author=R.+H.+Shoemaker&title=The+NCI60+human+tumour+cell+line+anticancer+drug+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The NCI60 human tumour cell line anticancer drug screen</span></div><div class="casAuthors">Shoemaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">813-823</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The US National Cancer Institute (NCI) 60 human tumor cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumors in anticancer drug screening.  This screening model was rapidly recognized as a rich source of information about the mechanisms of growth inhibition and tumor-cell kill.  Recently, its role has changed to that of a service screen supporting the cancer research community.  The author reviews the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ysyTSc1-p7Vg90H21EOLACvtfcHk0liv27Xhd4JIog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVCmu7c%253D&md5=c6c1a074b9dc7e138f45734499769284</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrc1951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1951%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520NCI60%2520human%2520tumour%2520cell%2520line%2520anticancer%2520drug%2520screen%26jtitle%3DNature%2520Rev.%26date%3D2006%26volume%3D6%26spage%3D813%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardarelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauna, Z. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fales, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4808</span><span class="NLM_x">–</span> <span class="NLM_lpage">4815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701208v&amp;key=10.1158%2F0008-5472.CAN-05-3322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701208v&amp;key=16651436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701208v&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvF2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4808-4815&author=J.+A.+Ludwigauthor=G.+Szak%C3%A1csauthor=S.+E.+Martinauthor=B.+F.+Chuauthor=C.+Cardarelliauthor=Z.+E.+Saunaauthor=N.+J.+Caplenauthor=H.+M.+Falesauthor=S.+V.+Ambudkarauthor=J.+N.+Weinsteinauthor=M.+M.+Gottesman&title=Selective+toxicity+of+NSC73306+in+MDR1-positive+cells+as+a+new+strategy+to+circumvent+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in Cancer</span></div><div class="casAuthors">Ludwig, Joseph A.; Szakacs, Gergely; Martin, Scott E.; Chu, Benjamin F.; Cardarelli, Carol; Sauna, Zuben E.; Caplen, Natasha J.; Fales, Henry M.; Ambudkar, Suresh V.; Weinstein, John N.; Gottesman, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4808-4815</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ATP-binding cassette (ABC) proteins include the best known mediators of resistance to anticancer drugs.  In particular, ABCB1 [MDR1/P-glycoprotein (P-gp)] extrudes many types of drugs from cancer cells, thereby conferring resistance to those agents.  Attempts to overcome P-gp-mediated drug resistance using specific inhibitors of P-gp has had limited success and has faced many therapeutic challenges.  As an alternative approach to using P-gp inhibitors, we characterize a thiosemicarbazone deriv. (NSC73306) identified in a generic screen as a compd. that exploits, rather than suppresses, P-gp function to induce cytotoxicity.  Cytotoxic activity of NSC73306 was evaluated in vitro using human epidermoid, ovarian, and colon cancer cell lines expressing various levels of P-gp.  Our findings suggest that cells become hypersensitive to NSC73306 in proportion to the increased P-gp function and multidrug resistance (MDR).  Abrogation of both sensitivity to NSC73306 and resistance to P-gp substrate anticancer agents occurred with specific inhibition of P-gp function using either a P-gp inhibitor (PSC833, XR9576) or RNA interference, suggesting that cytotoxicity was linked to MDR1 function, not to other, nonspecific factors arising during the generation of resistant or transfected cells.  Mol. characterization of cells selected for resistance to NSC73306 revealed loss of P-gp expression and consequent loss of the MDR phenotype.  Although hypersensitivity to NSC73306 required functional expression of P-gp, biochem. assays revealed no direct interaction between NSC73306 and P-gp.  This article shows that NSC73306 kills cells with intrinsic or acquired P-gp-induced MDR and indirectly acts to eliminate resistance to MDR1 substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOLtC7BqnRW7Vg90H21EOLACvtfcHk0liv27Xhd4JIog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvF2kt7w%253D&md5=9978857f34af74d365e415a0bd211ad7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3322%26sid%3Dliteratum%253Aachs%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DChu%26aufirst%3DB.%2BF.%26aulast%3DCardarelli%26aufirst%3DC.%26aulast%3DSauna%26aufirst%3DZ.%2BE.%26aulast%3DCaplen%26aufirst%3DN.%2BJ.%26aulast%3DFales%26aufirst%3DH.%2BM.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DSelective%2520toxicity%2520of%2520NSC73306%2520in%2520MDR1-positive%2520cells%2520as%2520a%2520new%2520strategy%2520to%2520circumvent%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4808%26epage%3D4815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-note1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a href="/doi/suppl/10.1021/jm701208v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_75173"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data for compounds <b>3−16</b>, <b>33</b>, <b>40</b>, <b>46</b>, and <b>48</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701208v/suppl_file/jm701208v-file008.pdf">jm701208v-file008.pdf (12.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701208v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm701208v%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701208v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                129KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995f32df7622d8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
